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Zinc is the second most abundant transition metal in the human body. In 
recent years, research on zinc homeostasis in mammalian cells has revealed 
distinct pools of zinc. Zinc is tightly bound to metalloproteins as a cofactor or 
structural component including metallothioneins that may provide a specific labile 
pool of zinc. The zinc-binding protein, Carbonic Anhydrase II (CA(II)) can be 
compartmentalized in intracellular organelles such as lysosomes, endosomes, 
endoplasmatic reticulum, mitochondria and the Golgi apparatus or in specialized 
organelles like synaptic vesicles and secretory granules. However, the 
concentration of “free” zinc inside cells is estimated to be at or below the 
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picomolar level.  Disruption of cellular Zn2+ homeostasis is implicated in several 
major disorders including Alzheimer's disease, diabetes, and cancer.  
The molecular mechanisms of Zn2+ physiology and pathology are 
insufficiently understood, owing in part to the lack of tools for measuring changes 
in intracellular Zn2+ concentrations with high spatial and temporal fidelity. To 
address this critical need, we have designed, characterized, and applied an 
intracellular protein-based sensor expressed in BL21(DE3) cells for the 
ratiometric imaging of Zn2+ based on the carbonic anhydrase (CA(II)) platform. 
FRET excitation ratiometric detection of intracellular Zn2+ occurs through Zn2+-
mediated energy transfer between dapoxylsulfonamide (Dps) bound to carbonic 
anhydrase and the fluorescent protein, mCherry fused to the C-termini of (CA(II)).  
The series of probes developed are expressible in various cell types, 
feature visible excitation and emission profiles, and show excellent selectivity 
responses for Zn2+ at intracellular concentrations. Furthermore, the ratio of the 
binding affinity for Zn2+/Cu2+ can be varied by mutations at Q92 and T199.  We 
demonstrate the value of the (CA(II))_mCherry sensor for biological applications 
by imaging induced changes in intracellular [Zn2+] in E. coli..   We anticipate that 
(CA(II))_mCherry and related probes will prove useful for elucidating the biology 




CHAPTER 1: Carbonic Anhydrase II-Based Metal Ion Sensing  
 
 
Role of zinc in biology: 
Transition metals, including zinc, copper, iron and nickel, are essential 
minerals for living organisms.  Zinc, the second most abundant trace element 
after iron, plays important catalytic, structural, and regulatory roles in cells. 
Bioinformatic analysis indicates that 3%-10% of the human genome encodes 
potential zinc binding proteins [1]. More than 300 zinc enzymes covering all six 
classes of enzymes have been discovered (reviewed in [2], [3], [4]); in many 
cases, the zinc ion is an essential cofactor for the observed biological function of 
these metalloenzymes.  Carbonic anhydrase was the first zinc-dependent 
enzyme discovered [5].  Additionally, various zinc-binding motifs that are 
important for stabilizing protein structure mediate diverse biological processes 
[6].   
Disturbance of zinc homeostasis can cause multiple disorders in human 
health.  Humans require a daily intake of several mg of zinc to maintain normal 
zinc levels [7].  Zinc deficiency, resulting from either genetic defect or dietary 
limitation, causes growth retardation, lethargy, gastrointestinal disorders, 
dermatological lesions, defects in reproductive organs, and dysfunction of the 
immune system [8]. Loss of function in zinc absorption transporters in the small 
intestine causes severe zinc deficiency and death in utero [9].   Furthermore, 
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increased vulnerability to infections is the leading cause of death among zinc-
deficient populations in developing countries [10]. Zinc supplementation has 
successfully been used as a treatment of many disorders, including 
acrodermatitis enteropathica (inflammation of the skin and the small intestine), 
age-related macular degradation and pediatric diarrhea [11].  Accumulating 
evidence also supports a role for zinc in the development of chronic diseases 
such as Alzheimer’s disease, diabetes, and asthma [12].  Excess zinc can induce 
aggregation of amyloid-β and formation of plaque [13], the hallmark of 
Alzheimer’s disease, and oral administration of zinc chelators substantially 
reduces the plaque formation in mouse models [14].  Decreased serum zinc 
levels are seen in Type I diabetes patients, and dietary supplementation with zinc 
reduces the incidence of chemically-induced diabetes in mice [15]. Furthermore, 
a missense mutant of the zinc transporter (ZnT8), believed responsible for 
inserting zinc into pancreatic beta cell insulin-containing vesicles, was identified 
as a risk factor for Type 2 diabetes [16].   Therefore, development of methods to 
better understand zinc homeostasis in cells and organs should have implications 
for the treatment of a number of diseases.  
 
 
Methods to measure total metal concentrations: 
A wide variety of analytical techniques are available for the determination 
and quantitation of metal ions in solutions.  Measurement of low concentrations 
of analytes in complex media, like seawater and blood, is increasingly important 
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for both biomedical and environmental applications.  In particular, determination 
of the concentrations of transition metals, including copper and zinc, is of great 
interest as these metal ions are essential for human health and can be toxic at 
elevated levels.   
Unlike iron or copper, zinc contains a filled d orbital (3d104s0) and 
therefore is not amenable to direct determination by optical absorption, emission, 
electron paramagnetic resonance, or related techniques.  Therefore, techniques 
such as atomic absorption spectroscopy, mass spectrometry and X-ray 
absorption spectroscopy have been employed to measure zinc.  Hybrid 
techniques (i.e. HPLC-atomic absorption spectroscopy, ICP-MS), in which 
separation of the species of interest is coupled with a metal specific detector, 
have been established as reliable and robust analytical tools for analysis of 
multiple metal ions in biological and environmental applications [17, 18]. The 
separation component of the coupled system is important when the target 
analytes have related chemical properties.  The choice of the detector depends 
on both the analyte concentration, and the required limit of detection. Because of 
its multi-element capability and low detection limits, inductively coupled plasma 
mass spectrometry (ICP-MS) is the most widely used method to measure the 
concentration of a given metal in complex mixtures [18]. Like all analytical 
techniques, ICP-MS has inherent limitations.  First, the sample is destroyed 
during metal analysis.   Second, ICP-MS measures the total metal concentration 
in a sample irrespective of the speciation of that metal, whereas in biological or 
environmental matrices it is often the concentration of the readily exchangeable 
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or bio-available metal ion that is of interest. Finally, ICP-MS cannot be used for 
real-time intracellular monitoring of metals.  Therefore, additional methods to 
quantify zinc concentrations are needed. 
New methods to measure and image metals in biological samples are 
under development.  Recently X-ray fluorescence spectrometry (XRF) has been 
employed to measure and image metal ions in cells and tissues [19].  XRF is a 
nondestructive method for the elemental analysis of solids and liquids, but is 
destructive to cells and typically requires dehydration of the sample prior to 
imaging.  In this method, the sample is irradiated by an intense x-ray beam that 
causes the emission of fluorescent x-rays from inner shell electrons of metal 
ions.  The spectrum of emitted x-rays is detected using either an energy 
dispersive or wavelength dispersive detector. The elements in the sample are 
identified by the wavelengths of the emitted x-rays, while the concentrations of 
the elements are determined by the intensity of those x-rays in comparison to 
standards [20].  This technique allows for simultaneous detection of >10 
elements with detection limits typically varying between 10 and 100 ppm dry 
weight, depending on the elements to be analyzed and the sample matrix [21].  
X-ray fluorescence has been useful for imaging metal ions within cells [22]; 
coupling XRF with traditional light microscopy allows the coupling of cell 
morphology with in vivo metal ion distribution. Like ICP-MS, an issue with XRF 
imaging is that quantitation is based on the total metal content and not the free 




Methods to measure “free” metal concentrations: 
The methods above allow for the measurement of the total metal 
concentration in a sample. However, zinc in biological systems is bound to 
myriad proteins and small molecules, thereby decreasing the “free” or readily 
exchangeable metal concentration by orders of magnitude and complicating 
analyses.  Consequently, fluorescence methods based on indicators whose 
emissions respond to bound metal have become the most prevalent approach for 
quantifying many divalent metals in both aqueous and biological samples. 
Fluorescent sensors are classified according to the receptor molecule and the 
fluorescent signal.  If the transducer is a molecule that is biological in origin, the 
sensor is called a biosensor (Figure 1.1).    
 
Figure 1:1:  Biosensor Paradigm: 
A sensor is termed a “biosensor” if the analyte is recognized by a molecule that is 








The success of fluorescent sensors in biology has been due in part to their ability 
to correlate analyte concentration distributions with the physical structures of 
cells and tissues. An array of fluorescent, zinc-selective chelators have been 
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developed and applied to zinc measurements (recently reviewed in [23], [24], 
[25], [26]). Many desirable traits of fluorescent metal ion indicator systems are 
now apparent.  Perhaps the most important consideration is high affinity and 
selectivity for zinc or other target metal ions; the probe must not only respond to 
free zinc but reject potentially interfering metal ions present at up to billion-fold 
higher concentrations.  Metal selectivity has been a limitation of many fluorescent 
sensors; these chelators often retain affinity for ions such as Ca2+ and Mg2+. 
While calcium or magnesium do not produce interference when present at equal 
concentrations with zinc, intracellular concentrations of these metals are 
significantly higher than that of free zinc [27], [28], [29], and therefore can 
interfere by saturating all of the metal binding sites of the fluorophore.  To 
quantify zinc concentrations in real-time, zinc should equilibrate with the sensor; 
therefore metal binding should be fast, reversible, and ideally of 1:1 
stoichiometry.  Furthermore, the sensor should have a metal affinity comparable 
to the free metal concentration. Reliable quantitation is essential for many 
studies, so a wavelength ratiometric, polarization, or lifetime response is 
necessary.  A sensor where the analyte binding only induces a change in 
fluorescence intensity is of modest use for quantitation because so many other 
factors can also cause apparent intensity changes, including:  changes in the 
probe concentration due to photobleaching or washout, variations in the 
excitation intensity or sample thickness, the presence of adventitious quenchers, 
and so on.  The potential for these artifacts led to the introduction of wavelength 
ratiometric indicators for pH and calcium [30], and later lifetime- [31], [32] and 
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polarization-based chemical analyses [33], all of which are largely free of these 
artifacts.     An excitation wavelength in the visible range or near IR is preferred 
so as to reduce damage to the cell and confounding autofluorescence.  For both 
in vitro and in vivo intracellular applications, solubility and membrane 
permeability are vital; furthermore, washout and nonspecific binding (e.g., to 
proteins) must be minimal.  The optimal properties of fluorescent sensors can 
depend on the proposed use for the sensor. 
 
Specific tools for monitoring Zn2+: 
Among the most important tools for studying the roles of metal ions such as Zn2+ 
in biology have been metallofluorescent indicators (sometimes called sensors).   
These indicators recognize the presence of free metal ions and indicate a 
change in fluorescence signal, which can be measured or photographed.  The 
change may be in the intensity (either enhancement or quenching), the excitation 
or emission wavelength, or in a few cases, the polarization or lifetime of the 
fluorescence [34], [35], [36].  There are several advantages to the fluorescence 
approach for studying metals in biology.  First, fluorescence can be imaged in 
cells, tissues, or living organisms, which enables analyte distribution to be related 
to the structure of the living cells or organisms.  Most imaging is done on a 
microscope, which permits the use of small samples.  Second, in good examples 
indicators are quite sensitive and specific for analyte, and respond rapidly 
enough to follow physiologically important processes.  Third, in some cases the 
indicators permit quantitative determination of analytes in situ, without sample 
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collection or processing, which may be infeasible on a subcellular level.  Fourth, 
by using protein or organelle-specific fluorescent stains and other indicators 
emitting at different wavelengths, the analyte level may be spatially related to a 
specific structure or organelle, or the distribution of another analyte in the cell.   
Finally, imaging or scanning can be used to screen a large number of specimens 
at high rates for fluorescence changes, which is routinely used to test candidate 
drugs for efficacy in treating disease.  For all these reasons, hundreds of 
fluorescent indicators and stains have been developed for different purposes.   
Various fluorescent indicators have been described for measuring zinc ion 
in solution and excellent reviews article have appeared recently [25], [24], [25], 
[26]; unfortunately, the scope of this necessitates the omission of much important 
work.  Most of these indicators are small organic fluorophores that also have 
multiple chelating moieties, such as amines or carboxylates, capable of binding 
the metal ion.  Early indicators (such as 8-hydroxyquinoline) were mostly ill-
suited for studying biological systems mainly due to a lack of specificity for zinc 
and toxicity compared to other metal ions more prevalent in biological matrices, 
such as calcium and magnesium [34], [35].  Frederickson developed the first zinc 
indicator widely used for biological specimens (TSQ: N-6-methoxy-8-quinolyl)-p-
toluenesulfonamide), which served as an histological stain for granular zinc in 
brain, pancreas, and other tissues [37].  However, the pH-dependence and 
insolubility of the 2:1 complex made TSQ poorly suited for soluble zinc and 
quantitation problematic.  Several important advances appeared with the 
introduction of the more soluble Zinquin [38], including exploitation of 
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dequenching by binding amine moieties [39], higher selectivity zinc binding 
moieties [40]; ratiometric response [41]; targeting to mitochondria [42] and high 
affinity [43], [44].  A significant proportion of these indicators are available 
commercially and, where appropriate, widely used.  While the development of 
these indicators has come a long way, no indicator or family of indicators offers 
high (or tunable) affinity, ratiometric or other accurate quantitation, rapid 
response, and targeting to desired cell types and/or organelles.   
Knowing the high selectivity with which biomolecules, such as proteins, 
bind metal ions, several workers constructed peptides or proteins with biomimetic 
metal ion binding sites and transduced the binding as changes in fluorescence 
using attached labels [45], [46], [47]. These indicators may be termed 
“biosensors” because of their use of biologically-derived molecules for 
recognition of the analyte.   Other investigators drew on the pioneering work of 
Miyawaki in developing FRET-based sensors [48], where the binding of zinc ion 
to a protein induces a conformational change, bringing two tethered fluorescent 
protein moieties closer  together, thereby improving their energy transfer  
efficiency [49], [50], [51].  While these approaches have been promising 
(particularly the prospect of an expressible indicator), until recently [52]  they had 
not demonstrated the high affinity and selectivity observed for natural metal ion 
binding sites.   As will be seen, the CA(II)-based biosensors offer all these 





Meldrum and Roughton discovered a new enzyme present in red blood cells that 
catalyzed the reverse hydration of CO2 to HCO3- [53], [54]. This enzyme, named 
carbonic anhydrase, was identified as the first zinc metalloenzyme.  For both the 
in vivo function and the use of CA in sensors, the affinity and selectivity of metal 
ion binding to the active site is key.  The crystal structure of human CA(II) 
demonstrates that the active site, located in the central region of a ten stranded, 
twisted β-sheet, is comprised of a cone shaped cleft, 15 Å deep, with a 
tetrahedral Zn2+ ion at the bottom of the cleft [55], [56]. The imidazole side chains 
of three histidine ligands, at positions 94, 96 and 119, are directly coordinated to 
the metal center.  These direct ligands form hydrogen bonds to the indirect 
ligands Gln-92, Asn-244 and Glu-117, respectively.  Filling out the coordination 
sphere of zinc is a hydroxide ion that forms a hydrogen bond to Thr-199 at 
neutral pH.  With the exception of Asn-244, which is hydrogen bonded to His-96 
through the main chain carbonyl oxygen, the direct and indirect metal ligands are 
invariant in all sequenced catalytically active α-carbonic anhydrases [57], [58]. 
This prototypical metal site is completed by hydrophobic residues that surround 
the zinc site. By comparison, the beta class of carbonic anhydrases contains a 
HisCys2H2O zinc polyhedron [59]. 
 
Determinants of metal affinity of CA(II): 
Metal affinity is determined by optimal interactions between the CA(II) 
metal ligands and the bound metal ion. The nature of the metal ligands, the 
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hydrogen bond network and the hydrophobic shell all contribute to the picomolar 
metal affinity of CA(II) [55], [56]. Large changes in metal affinity occur by altering 
the number of metal ligands.  Substitution of one of the histidine side chains with 
alanine decreases the metal affinity by at least 105-fold (Figure 1.2), while 
introduction of a fourth ligand into the metal coordination sphere of CA(II) by 
replacing T199 with Glu, Asp or Cys increases the affinity up to 100-fold [60], 
[61]. Spectroscopy and crystallography demonstrate that the new thiolate side 
chain coordinates to the metal ion, displacing the metal-bound solvent molecule.  
Furthermore, substitution of any of the His ligands with another side chain 
capable of coordinating the zinc ion, such as Asp, Glu, Gln, Asn or Cys, 
substantially decreases zinc affinity [62], [63], [64], [65], [66].  Crystal structures 
of these variants demonstrate that none of these side chains position the 
coordinating atom at the same place as the imidazole nitrogen, leading to 







Figure 1:2:  Schematic diagram of the active site of WT CA(II): 
Substitutions in both  direct (H94) and indirect (E117, T199, Q92)  ligands 
decrease the zinc affinity of CA(II) by 5- to 105 –fold, and dramatically reduce 




Deletion of any one of the hydrogen bonds with the second shell ligands 
also reduces zinc affinity although this effect is more modest, decreasing zinc 
affinity 10 – 40-fold [67], [68].  Thermodynamic measurements of metal binding 
demonstrate that modifications in the metal polyhedron of CA(II) lead to a 
complex series of changes in both the enthalpy and entropy of ligand binding that 
is most readily rationalized in terms of metal and protein desolvation, rather than 
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in terms of changes in the direct interactions of ligand and protein [69].  Although 
the second shell ligands were proposed to function primarily by orienting the 
direct ligands, mutations in these residues produce profoundly different effects on 
the enthalpy of binding, depending on the nature of the residue.  These results 
indicate that the second shell ligands make both enthalpic and entropic 
contributions to metal binding.   
Finally, alterations in the hydrophobic residues (Phe-93, Phe-95 and Trp-
97) underneath the zinc binding site decrease the metal affinity of CA(II) by as 
much as 100-fold [70], [71].  Crystal structures of these mutant proteins 
demonstrate alterations in the structure of the apo-enzyme such that the histidine 
side chains are no longer correctly oriented to bind zinc [72].  In addition to 
providing fundamental insight into the determinants of metal affinity, the metal 
affinity of these CA(II) variants span the range from subpicomolar to micromolar 
thereby providing an array of CA(II) proteins that could be used to measure a 
wide range of zinc concentrations. 
 
Kinetics of zinc ion binding to CA(II): 
 In CA(II), zinc equilibration is limited by both the high zinc affinity (pM) and 
the slow dissociation rates.  The measured association rate constant at  
~105 M-1s-1 is much slower than a diffusion-controlled limit of 107-108 M-1 s-1 
leading to a half-time for dissociation estimated at several months [67], [73].  The 
slow association rate constant suggests that metal binding occurs in a two-step 
mechanism:  formation of an initial complex followed by a conformational change 
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(Scheme 1.1).  The apparent association rate constant increases significantly for 
mutants with one of the histidine ligands replaced with alanine (His2 zinc site) or 
the second shell hydrogen bond between His119 and E117 removed (E117A 
mutant) [64], [67].  These mutations suggest that the kinetic mechanism for zinc 
binding occurs via an intermediate where the zinc ion is bound to the two ligands 
nearest the active site surface, His94 and His96, followed by slow addition of the 
third His ligand (H119) and dissociation of water ligands to form the tetrahedral 
metal site (Scheme 1.1; [67]).  The E117A mutation has proven particularly 
useful for zinc sensing since this mutation decreases the half-time for zinc 
dissociation by 5000-fold while only decreasing the zinc affinity by 40-fold [67]. 
 
    
Scheme 1.1:  Proposed Mechanism of Zinc Binding to CA(II) 
 
 
Equilibration of CA(II) with zinc can be facilitated by the addition of certain 
chelators, including dipicolinic acid (DPA) [74], [75], but not others, including 
EDTA.   Catalysis of metal exchange by DPA is proposed to occur by the 
formation of a CA(II)-DPA-Zn2+ ternary complex (Scheme 1.2); the apparent 
association rate is increased because CA(II) binds DPA-bound Zn2+ which is in 
higher concentration than the “free” zinc and the dissociation rate constant is 
enhanced by the bound DPA [75].  This type of chelator-catalyzed zinc exchange 
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could mimic intracellular mechanisms that are proposed to enhance zinc 











Metal specificity of CA(II): 
Through evolution, the structure of CA(II) has been selected to bind Zn2+ 
in the presence of a variety of potential cellular interferents, including:  Mg2+ 
(estimated free concentration of 0.5-1 mM) [27], Ca2+ (est. free concentration of 
0.05-1 µM) [28], [77], [78] Fe2+ (est. free concentration of 0.1-10 µM) [79], [80], 
[81], [82], and Cu2+ (est. free concentration of ~ 10-18 M [83].)  Like small 
molecule ligands, the metal affinity of wild type CA(II) follows the Irving-Williams 
series (Mn2+ <Co2+ <Ni2+ <Cu2+ >Zn2+) although the zinc affinity is increased 
significantly compared to the rest of the transition metals (Figure 1.3) [66], [84], 
[85].  Copper could potentially compete with zinc for binding to CA(II) in a cell 
since the affinity is 10-fold higher than zinc; however, the readily exchangeable 
copper concentration is estimated at >>1000-fold lower than that of zinc [86].  
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CA(II) has little affinity for other possible competitors; the dissociation constant of 
CA(II) for Ca2+ and Mg2+ is larger than 10 mM and the affinity of Fe2+ is estimated 
to be significantly higher than 100 µM [85].  Therefore, CA(II) has significantly 
higher metal selectivity compared to small molecule chelators such as EDTA, 
NTA, DPA and TPEN that have little discrimination in binding affinity between Co, 









Figure 1:3:  Divalent metal ion affinities of WT CA(II): 
The metal ion affinity of CAII follows the inherent metal ion-ligand affinity trend 




Table 1.1:  Selectivity of CA(II):  
pKd of M2+ of several small molecules chelators of  CA(II).  Asterisk indicates that 




Structures of metal-substituted CA(II) enzymes reveal that the geometry of 
the metal site often varies with the identity of the metal.  For example, copper 
binds to wild-type CA(II) in a trigonal bipyramidal geometry, accepting an 
additional water as a ligand while both bound manganese and nickel are 
octahedral with three water molecules [56], [87].  The enthalpy of metal binding 
to CA(II) decreases through the series Co2+→Zn2+→Cu2+, mirroring the enthalpy 
of hydration, suggesting that desolvation of the metal ion plays an important role 
in metal affinity and selectivity [88].  
The metal selectivity of CA(II) is also determined by the structure of the 
active site.  Mutagenesis of the His ligands to another side chain capable of 
coordinating Zn2+, including Asp, Glu, Gln, Asn, and Cys, leads to CA(II) variants 
with altered metal selectivity [66].  For example, the selectivity for zinc compared 
to copper (KZn/KCu) varies from 0.1 to 2 x 10-4 to 15 for wild-type, H119N, and 
H119Q CA(II), respectively  Similarly, the selectivity for zinc compared to nickel 
(KZn/KNi) varies from a value of 2 x 104 for wild-type CA(II) to 1 for the H94D 
mutant.  Nonetheless, except for H119Q CA(II), the metal selectivity of all of 
these mutants follows the inherent metal ion affinity trend suggested by the 
Irving-Williams series, demonstrating the importance of this trend for metal ion 
selectivity in biology.   Furthermore, neither the polarizability of the liganding side 
chains nor the size of the metal ion binding site correlate strongly with metal ion 
specificity; instead, changes in metal ion specificity in the variants correlate with 
the preferred coordination number and geometry of the metal ion [58].  This 
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correlation suggests that a primary feature driving deviations from the inherent 
ligand affinity trend is the positioning of active site groups such that a given metal 
ion can adopt a preferred coordination number/geometry.   
The hydrophobic residues underneath the zinc binding site in CA(II) also 
contribute to metal selectivity.  As the hydrophobicity and size of the amino acids 
at positions 93, 95 and 97 decrease, the affinity of CA(II) for metal ions that bind 
with a tetrahedral geometry, zinc2+ and cobalt2+, decreases [71, 89]. In contrast, 
the affinity of CA(II) for the trigonal bipyramidal Cu2+ increases significantly.  
These two trends contribute to the enhanced copper selectivity for these mutants 
with values of KCu/KZn as high as 106.  A comparison of the crystal structures of 
the apo forms of wild-type and F93I/F95M/W97V CA(II) demonstrates that 
mutations in the hydrophobic residues disrupt the positioning of the His ligands in 
a tetrahedral geometry in the absence of bound metal [72]. Therefore, this 
hydrophobic shell is important for stabilizing the tetrahedral metal ion geometry 
for zinc and destabilizing alternative geometries, such as the trigonal bipyramidal 
geometry of copper.  
 
 
CA-based zinc sensing:  ratiometric fluorescent sensors: 
Most of the CA-based zinc sensors rely on the zinc-dependent binding of 
a ligand to the protein. Aryl sulfonamides have long been known to inhibit holo-
carbonic anhydrase [90]. Hundreds of these compounds with various structural 
properties and activity have been identified, some of which are being used to 
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treat glaucoma.  The mechanism for inhibition is well-understood; aryl 
sulfonamides contain the weakly acidic SO2NH2 moiety that directly coordinates 
the zinc ion through the ionized NH- group, displacing the zinc bound water [91]. 
The first approach to fluorometrically determine zinc using carbonic anhydrase as 
a recognition element evolved from the work of Chen and Kernohan [92].  They 
discovered that the fluorescence emission of the aryl sulfonamide, dansylamide 
(DNSA), upon binding to holo-carbonic anhydrase is both enhanced significantly 
and blue-shifted. Thompson and Jones [93] determined that DNSA has very 
weak affinity for apo-CA and thus the fraction of CA with bound DNSA reflects 
the fraction of zinc-bound CA, which is determined by the free zinc concentration.  
Therefore the ratio of emissions from free and bound dansylamide could be used 
to determine the free zinc concentration.  To optimize CA-based fluorescence 
sensors for accurate quantitation, the metal ion binding has been transduced 
using wavelength ratiometric indicators as well as lifetime- and polarization-
based methods [94], [95], [96], [97].  Wavelength ratiometric measurements have 
been applied to quantification of free zinc in biological samples.  Zinc release 
from brain cells in a rabbit ischemia model was measured by adding apo–CA to 
the dialysate in the brain of a living rabbit and then quantifying zinc 
concentrations from the fluorescence emission ratio after addition of DNSA [98].   
Similarly, neuronal zinc release from organotypic cultures of mammalian 
hippocampus following electrical stimulation was measured using apo-CA(II) and 
a water-soluble aryl sulfonamide, ABD-N, with an improved extinction coefficient 
and a longer excitation wavelength [94]. In both of these cases the exchangeable 
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zinc concentrations (1-100 nM) are much higher than the KZn for CA(II) (1 pM), 
therefore the measurements were carried out using high concentrations of apo-
CA(II) and sulfonamide (1-20 µM) such that zinc binds to CA(II) 
stoichiometrically.  In this linear relationship, the detection limit is established by 
the lowest fractional occupancy that can be reliably measured, which is usually 
considered as 0.1%; therefore, the dynamic range is thus largely determined by 
the concentration of apo-CA(II).  Stoichiometric methods depend on accurate 
knowledge of the concentration of CA(II) and maintaining an excess 
concentration of both CA(II) and sulfonamide.  Therefore, stoichiometric methods 
do not work for in vivo measurements where the total zinc concentration is high 
(~0.2 mM) and well buffered by numerous ligands and consequently difficult to 
deplete.  
To address these issues, an excitation ratiometric method was developed 
based on Förster resonance energy transfer (FRET) [99] between a cell-
permeable sulfonamide, Dapoxyl sulfonamide, and a second fluorophore 
attached to CA(II)  (Figure. 1.4) [100].  The fluorophore that is covalently 
attached to CA(II) serves as a FRET acceptor for the bound sulfonamide, such 
that emission from the bound sulfonamide is efficiently transferred to the label on 
the protein, which emits at much longer wavelengths. In this case, the label is 
AlexaFluor594 maleimide (AF594, Ex 594/Em 617) that is attached to the thiol 
group of a unique cysteine (H36C/C206S) engineered on the surface of CA(II); 
the position of the label on CA and the overlap of its absorbance with the 
emission of Dapoxyl sulfonamide are chosen so that energy transfer from the 
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sulfonamide to the AF594 is nearly quantitative.   For this sensor, when Dapoxyl 
sulfonamide bound to AF594-CA(II) is excited at 365 nm, fluorescence emission 
is observed at 617 nm from the AF594 because of FRET. Thus the UV-excited 
red emission (Ex 365 nm/Em 617 nm) represents the fraction of AF594-CA(II) 
with sulfonamide (and therefore zinc) bound, whereas the signal of the directly 
excited AF594 (Ex 548 nm/Em 617 nm) represents the total amount of the 
AF594-CA(II).  The fluorescent ratio of UV excited (365 nm) to directly excited 
(548 nm) emissions correlates with the zinc-bound fraction of the sensor and 
thus free zinc.  In vivo calibrations are carried out using a series of nitrilotriacetic 
acid (NTA)-chelated zinc buffers in which the free zinc concentration is 
maintained at a fixed level, indicating that the apparent zinc affinity of this sensor 
is ~140 pM.  An important advantage of this approach is the relative insensitivity 
to the sulfonamide level, sulfonamide bound to membranes and proteins, and 
adventitious holo-CA(II) present in the specimen, since only the fraction of the 
sulfonamide in close proximity (effectively, bound) to the labeled CA(II) is 
observed.  Also, even though UV excitation is used, the large difference between 
the excitation and emission wavelengths leads to a very low autofluorescence 
background.  
This sensor was applied to measure the intracellular free zinc 
concentration in the mammalian cell line PC-12 under resting conditions [29].  
Because AF594-CA(II) is ordinarily cell-impermeant, an 11 amino acid cell-
permeating peptide (TAT-tag derived from HIV-1 protease) was fused to the N-
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terminus to facilitate uptake [101].  Using this method, the concentration of free 





Figure 1:4:  FRET excitation ratiometric Zn2+ sensing scheme:  
In the presence of zinc, dapoxyl sulfonamide binds to holo-CA(II) and transfers 
energy to the acceptor, AlexaFluor 594.  The ratio of the acceptor fluorescence 
emission with excitation of the donor to that with excitation of the acceptor is 
measured.  The FRET intensity ratio increases with zinc concentration as the 
fraction of zinc-bound CA(II) increases,  producing a binding curve with picomolar 




equilibration between CA(II) and the readily exchangeable zinc concentration.  
To examine whether zinc equilibration in vivo occurs readily despite the slow zinc 
association rate constant in vitro, we demonstrated that the measured zinc 
 
 23 
concentration is not dependent on the concentration of sensor or on the 
equilibration time (20 min to 24 h).  Furthermore, the same “free” zinc 
concentration in PC12 cells is observed using the AF594-labeled E117A CA(II) 
mutant as the receptor molecule where the zinc equilibration rate is increased by 
800-fold [102].  The picomolar affinity of this CA(II) sensor is the most sensitive 
sensor used to measure cellular zinc to date. 
In addition to measuring the readily exchangeable zinc concentration, 
these data have further implications for the mechanism of cellular zinc 
homeostasis.  First, these data indicate that there is a substantial exchangeable 
zinc pool in the cell; the concentration of the CA(II) sensor is in the nanomolar 
regime providing a lower limit for the exchangeable zinc pool.  Since the total 
zinc concentration in cells is ~0.2 mM, an exchangeable zinc pool in the 
nanomolar to micromolar range is still a small percentage of the total cellular 
zinc.  Second, the rapid equilibration of the sensor with the readily exchangeable 
zinc concentration is inconsistent with the CA(II) sensor binding the picomolar 
“free” zinc with the 105 M-1s-1 association rate constant measured in vitro since 
the estimated equilibration half-time for this reaction is on the order of several 
hours.  These data suggest that zinc may bind to CA(II) via a zinc-chelator 
complex in vivo, where the chelator is either a small molecule or protein 
chaperone, perhaps similar to the mechanism of DPA-catalyzed zinc binding to 
CA(II) (Scheme 1.2).  In summary, these data indicate that there is a readily 
exchangeable pool of cellular zinc that equilibrates rapidly with zinc-binding 
proteins such as carbonic anhydrase. 
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Carbonic anhydrase with wild-type zinc affinity is ideal for measuring the 
cellular zinc concentration under equilibrium conditions for most cells. However, 
free zinc concentrations in neuronal models vary over 7 orders of magnitude from 
10 pM in normal resting cells to more than 10 µM outside the neurons after 
stimulation of synaptic zinc release [29], [103], [104].  To measure zinc 
concentrations over this wide dynamic range, CA(II) receptors with altered zinc 
affinities, such as CA(II) mutants described previously will be of great utility [105].  
 
 
Other zinc sensing methods using CA(II): 
Fluorescence anisotropy is another ratiometric approach that provides an 
accurate alternative for quantification, especially for fluorophores with smaller 
changes in lifetime and quantum yield.  In some cases fluorescence anisotropy 
offers a particular advantage of an expanded dynamic range, as observed for the 
carbonic anhydrase-based sensor [106], [107], [108].   Fluorescence anisotropy-
based sensing has not been widely used for cellular studies, perhaps because 
fluorescence polarization microscopes are less common than those permitting 
wavelength ratiometric determinations of analytes. 
 CA-based sensors can also be used to measure zinc concentrations 
based on changes in fluorescence lifetime.  Fluorescent aryl sulfonamides, 
including dansylamide and Dapoxyl sulfonamide, exhibit substantial changes in 
their average fluorescence lifetimes upon binding to holo-CA, consistent with the 
increases in the apparent quantum yield [92], [97].  Using standard time- or 
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frequency-domain methods, the proportions of the lifetimes corresponding to the 
free and bound forms of the sulfonamide can be determined, and therefore, the 
free zinc concentration can be calculated in the same manner as for the 
wavelength ratiometric approaches. Lifetime-based methods have advantages 
similar to those of ratiometric determinations; however, microscopes capable of 
imaging fluorescence lifetimes are still uncommon [109]. 
 
Environmental applications using CA(II)-based sensors: 
CA(II)-based sensing has also been applied to the determination of metal 
ions, such as Cu2+ and Zn2+, in natural waters.   Cu2+, Zn2+, and to a lesser extent 
Cd2+, Co2+, and Ni2+ are of interest environmentally for two main reasons.  First, 
Cu and Zn are nutrients required by essentially all organisms, and their 
availability (together with Fe) in natural waters effectively controls the growth of 
phytoplankton and thus all other organisms in the food chain as well.   As a 
consequence, Cu and Zn typically exhibit a “nutrient distribution” in the ocean, 
with low levels in the sunlight-exposed photic zone near the surface, and 
elevated concentrations at greater depth [110].  Second, Cu and Zn at elevated 
levels are toxic to many life forms, and are thus important pollutants in many 
harbors and estuaries [111].  For instance, the blue mussel, a commercially 
important shellfish, is killed by Cu2+ at sub-ppb levels [112].  Speciation of metal 
ions in natural waters (e.g., the proportion of total metal bound to different 
ligands, particles and colloids in a sample) is important, because it determines 
the availability of the metal ions to various organisms; conversely, the marine 
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biota have a dramatic influence on the speciation and distribution of biologically 
important metals [110], [113].  The importance of these questions has led to 
substantial study of the marine geochemistry of these metal ions.   
Copper sensing using CA(II) is based on copper binding to the His3 metal 
site and quenching the fluorescence of a fluorophore, such as Oregon Green, 
that is covalently attached to a unique Cys residue near the metal site, such as 
L198C [114].  Copper binding to fluorophore-labeled CA(II) results in a 
concomitant decrease in fluorescence intensity and lifetime, the latter of which 
results in increased modulation and decreased phase angle [115], [116].  The 
free Cu2+ concentration can be determined under equilibrium conditions from the 
observed lifetime or phase angle in comparison to a standard curve. The CA(II) 
variants with altered copper affinity and enhanced copper selectivity will be useful 
for limiting interference from Zn and for measuring a variety of copper 
concentrations.  Other metal ions such as Co2+, Cd2+, and Ni2+ also exhibit 
quenching of suitably positioned fluorophores upon binding to the active site of 
CA and can be quantified by changes in fluorescence intensity, lifetime, or 
fluorescence polarization [95]. 
The high sensitivity and selectivity of CA-based fluorescence sensors for 
zinc and copper are well suited to determining free metal ions in the complex 
matrix of sea water.   CA-based sensors offer some unique advantages in 
comparison to other methods of determining free metal ion concentration (and 
thus speciation).  First, compared to CA-based sensing, existing (mainly 
voltammetric) methods of determining free Cu2+ and Zn2+ in sea water are 
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relatively slow and labor intensive, such that only a few samples a day can be 
analyzed by a skilled practitioner [117], [118], [119]; by comparison, CA-based 
sensors can determine these metals in sea water without any processing or 
separation steps, and can also act as a true sensor, providing a continuous 
readout of metal ion concentration in situ, in real time [120].  Also, the 
fluorescent-labeled CA(II) can be immobilized at the end of an optical fiber, which 
can be immersed and the metal ion concentration determined remotely in situ at 
some depth in the water column [109]. This is of importance since collecting 
water samples is slow and expensive, and risks contamination of the samples 
compared with determination in situ with a fiber optic sensor.  In view of the 
power and flexibility of the CA-based fluorescence sensors, we anticipate they 




CONCLUSIONS AND FUTURE WORK 
CA(II)-based sensors have been demonstrated to quantify readily 
exchangeable zinc concentrations in mammalian cells and “free” Cu2+ 
concentration in seawater.  These sensors have a bright future for examining 
zinc concentrations and changes in zinc concentrations in a wide variety of cells 
and subcellular organelles as well as in tissues.  The ability to measure readily 
exchangeable zinc concentrations using CA(II)-based sensors is an important 
new tool for answering biological questions concerning intracellular zinc storage 
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and distribution, the role of zinc in signaling pathways as well as the pathological 
roles of zinc in human disease.  In the future, this sensor may also find important 
applications in measuring the readily exchangeable concentration of other metal  
ions, including copper, in cells and in seawater. 
 
Expressible ratiometric CA(II)-based sensors: 
Although TAT-tag mediated delivery of ratiometric CA sensors has been 
successfully applied to mammalian cell lines, it cannot penetrate some other 
organisms without detrimental effects [121].  Also, the chemical labeling of the 
isolated protein with the AlexaFluor fluorophore is tedious, labor intensive, and 
does not always proceed in high yield.  A further improvement in zinc sensors 
would be to further develop and optimize a protein-based sensor that can be 
readily expressed in cells [122], [123].  The expressible sensor can be 
constructed by fusing a fluorescent protein to CA(II) as a fluorescence acceptor 
and using a zinc-dependent FRET donor, like the Dapoxyl sulfonamide used in 
the previous sensor. The relatively small size of the fluorescent protein variants 
and CA(II) generally means that efficient energy transfer between the Dapoxyl 
sulfonamide and the fluoresecent protein acceptor is feasible.  An ideal candidate 
fluorescent protein for an expressible CA sensor should meet the following 
criteria: excitation spectrum overlap with the emission of Dapoxyl sulfonamide to 
ensure good FRET efficiency, high extinction coefficient and quantum yield, fast 
maturation, and monomeric state. Directed evolution studies have generated a 
large pool of fluorescent proteins that can be used for this purpose [124], such as 
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variants of RFPs from Discosoma sp. and Entacmaea quadricolor [125], [126], 
[127].  Furthermore, fluorescent proteins with different spectra can be coupled to 
CA variants with different zinc affinities, thus creating a multicolor measurement 
covering a wide dynamic range in a single experiment.   Our initial experiments 
have used mOrange and mCherry [127]  in fusion proteins; this work is ongoing, 
including the use of sequences to target the expression to particular organelles 
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Many proteins bind various transitional metals with high affinity.  
Furthermore, the affinity varies with the identity of the metal and the metal 
cofactor is usually critical to the biological function of the protein. The 
incorporation of the correct metal into metalloproteins, including Carbonic 
Anhydrase, is dependent on both the concentration of the metal ion in vivo and 
the affinity of the protein [66].  Even where metallochaperones transport the 
metal ion in vivo, selectivity is required [128].  Typically transition metal binding 
sites are comprised of 3-4 protein ligands that are embedded in a hydrogen 
bond network.  These hydrogen bond interactions make structural and 
electrostatic contributions that orient the ligands for optimal metal coordination 
and reactivity [64].  For example, D124 in Cu, Zn superoxide dismutase plays a 
role in metal binding by forming hydrogen bonds with histidine ligands to zinc 
and copper [129].  Variants of this enzyme show that when these hydrogen 
bonds are disrupted, the ability to coordinate zinc is virtually lost. Substantial 
effort to create high-affinity transition metal proteins via de novo design and 
genetic engineering have advanced the understanding of the determinants of 
these sites and sensing technology. 
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Structure-function relationships in protein-zinc binding sites have been 
extensively delineated via studies of the active site structures in carbonic 
anhydrase. Carbonic anhydrase II (CA(II)) contains a conserved His3H2O zinc 
polyhedron which is essential for catalysis.  The largest alterations in metal 
affinity in carbonic anhydrase have been obtained by altering the number and 
chemical nature of the His side chains that directly coordinate [130].  Removal of 
one ligand (His2 sites) decreases Zn affinity > 105 fold.  In contrast, CA(II) 
mutations that replace the solvent molecule with a fourth protein ligand enhance 
the zinc affinity up to 200-fold [61]. 
Additional features of metal ion binding sites that have been hypothesized 
to alter affinity and selectivity in CA(II) and other metalloproteins are polarizability 
of the coordinating atom, size of the binding site relative to size of the metal ion, 
and the binding site geometry.  In wild-type CA(II), the hydrogen bond network 
that fully saturates the zinc ligands (H94, H96, H119) and the hydroxide ion of 
the tetrahedral metal coordination polyhedron are referred to as the second shell 
residues or the “indirect” zinc ligands (Figure 2.1).  The direct histidine ligands 
His 94 and His 119 of carbonic anhydrase form hydrogen bonds with the side 
chains of the residues Q92 and E117, respectively. Mutation of any of these 
second shell ligands to alanine decreases zinc affinity 10-20-fold [131]. The loss 
of zinc affinity could arise from alterations in the thermodynamics of the His−Zn 
interaction in the bound versus unbound states or changes in the 
thermodynamics of solvation of the active site. In wild-type CA(II), one of the 
carboxylate oxygens of Glu-117 accepts a hydrogen bond from an imidazole N-H 
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of the direct ligand His-119 (Figure 2.1); this interaction is postulated to 
preorganize the binding site and thereby enhance the overall affinity for the 
active site zinc [132]. The crystallographically determined structure of E117A 
CA(II) is very similar to that of wild-type protein. In addition to decreasing the zinc 
affinity, removal of the Glu-117−His-119 hydrogen bond significantly enhances 
the zinc association rate constant. These data have led to a proposed 
mechanism for zinc binding that involves an initial complex formed by zinc 
coordination to His-94 and His-96, followed by slow ligand exchange 
The zinc bound water ligand forms a hydrogen bond with the side chain of 
Thr-199.   Zinc binds to CA(II) in tetrahedral geometry with one bound water 
molecule while bound copper forms a trigonal bipyramidal geometry with two 
water molecules [133].  Therefore, we proposed that alteration of the hydrogen 
bonding network with the metal-water molecules and/or the volume of the active 
site near these molecules would alter the copper/zinc selectivity.  Here we 
demonstrate that replacement of Thr199 with amino acids that cannot form a 
hydrogen bond decreases zinc affinity while substitution of amino acids capable 
of hydrogen bonding with the zinc-water ligand have little or no effect on zinc 
affinity.  These results demonstrate that hydrogen bonding interactions with the 
zinc-water ligand stabilize the bound metal ion.  In contrast, mutations that 
disrupt the hydrogen bond with the zinc-water ligand enhance the copper binding 
affinity. These data demonstrate that the hydrogen bond with the metal-water 





























Figure 2:1:  Ribbon diagram of human Carbonic Anhydrase II:  
Metal binding site highlighting: the zinc ion as a sphere; the direct ligand 
histidines, H94, H96, H119; the second shell ligands Q92, E117, T199; and 
hydrophobic residues F93, F95, W97 
 
The goal of the work presented in this chapter is to first construct, via 
protein engineering, CA(II) metal ion sensors with predictable structure and 
function-zinc and copper affinities.  Secondly, in addition to preparing new CA(II) 
variants and analyzing their metal affinity, the fluorescent properties and stability 
for incorporation into sensors useful for measuring Cu(II) and Zn(II) at sea, were 
optimized.  These studies provide insight into the design of CA(II) mutants with 




MATERIALS AND METHODS 
 
Vector construction and mutagenesis: 
 The CA(II) variants with substitutions at threonine-199 and glutamine-92 
were prepared using the pACA vector, encoding human CA(II) under the control 


















Figure 2:2:  Sequence of human CA(II):  
DNA sequence encoding the gene for human carbonic anhydrase II.  The 
highlighted nucleotides indicate the codons for glutamine-92 and threonine-199.  














Carbonic Anhydrase (II) Variant Position 92  Position 199 
Wild Type  CAG ACC 
Q92A GCA ACC 
Q92L CUG ACC 
T199A CAG GCC 
T199G CAG GGC 
T199I CAG ATC 
T199N CAG AAC 
T199S CAG TCC 
T199V CAG GTC 
Table 2.1:  Nucleotide mutations for site-directed amino acid mutagenesis: 
For each amino acid mutation, the original codon in WT CA(II) and the mutated 




The Quik-Change site-directed mutagenesis methodology utilizes two 
completely complementary primers centered on the desired mutation to generate 
new plasmid DNA encoding the mutated protein [135].  In addition to altering the 
sequence of the second shell ligand, the asparagine at position 67 was mutated 
to cysteine (N67C) to allow labeling of protein with an extrinsic fluorophore.  The 
resulting DNA was transformed into chemically competent Smart cells 
(Genlantis).  The transformed cells were plated onto LB-agar plates with 100 
µg/mL ampicillin and incubated at 37°C overnight.  Single colonies were used to 
inoculate 50 mL LB-amp liquid cultures, and grown overnight at 37°C. The 
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plasmid DNA was isolated using the Qiagen Hi-Speed Midi Plasmid Kit and the 
DNA sequence of the CA(II) gene in the purified plasmids was determined using 
the dideoxy method of Sanger et al. (1977) [136]. 
 
 
Protein expression and purification: 
 Chemically competent BL21(DE3) E. coli were transformed with the 
appropriate plasmid and grown overnight on selective LB-amp agar plates. A 
single colony was selected from the LB-amp plates and grown overnight at 37°C 
in liquid LB-amp culture. A 1:200 dilution of the overnight culture was used to 
inoculate the expression culture of LB media with 0.5x M9 salts, 0.4% glucose, 
100 µg/mL ampicillin, 0.42 mM ZnSO4 and grown at 37°C to OD600 nm = 0.8 – 1.  
CA(II) protein overexpression was induced by the addition of 0.25 mM isopropyl-
β -D-thiogalactopyranoside (IPTG) and additional ZnSO4.  After 3 hours of growth 
at 30°C, protease inhibitors (7.4 µg/mL phenylmethanesulfonyl fluoride (PMSF) 
and 0.92 µg/mL tosyl-L-argininyl-methyl ester (TAME), final concentrations) were 
added. The cells were harvested 3 h later (6 h after induction) by centrifugation at 
4°C for 15 min at 5,000 rpm. The cell pellet was resuspended in 25 mL per liter of 
culture of cold lysis buffer (50 mM TRIS-SO4 pH 8.0, 50 mM NaCl, 10 mM EDTA, 
200 µM ZnSO4, 1 mM dithiothreitol (DTT), 10 µg/mL PMSF and 1 µg/mL TAME) 
prior to flash freezing. 
After slow thawing, the cells were lyzed using a microfluidizer and the 
cellular debris removed by centrifugation (45 min, 12,000 rpm).  Streptomycin 
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sulfate (10%) was added at 4 °C and precipitated ribosome and nucleic acids 
were removed by centrifugation (30 minutes, 10,000 rpm). The resulting protein 
solution was dialyzed against buffer A (30 mM HEPES, pH 8.0, 0.2 mM ZnSO4, 
and 1 mM DTT) in preparation for anion exchange chromatography. For all 
dialysis steps, the protein solution was dialyzed against 4 L of buffer overnight at 
4°C. In the first purification step, the protein mixture from 1 L of culture is 
incubated with 25 mL of DEAE Sephacel (Amersham Bioscience), equilibrated 
with buffer A, for at least 30 min at 4 °C. The resin is then put into a column. 
CA(II) does not bind to the resin under these conditions and is collected in the 
flow-through.  The column is then washed with 1 column volume of buffer. 
Generally CA(II), at this stage, is >90% pure and can be used immediately. If 
further purification is needed, the protein is dialyzed against buffer B (10 mM 
MES, pH 7.0, 0.1 mM ZnSO4 and 1 mM tris(2-carboxyethyl)phosphine 
hydrochloride (TCEP)), and then incubated with 30 mL SP Sepharose 
(Amersham Bioscience) per liter of culture equilibrated in buffer B and incubated 
for 30 min at 4°C. The resin is then washed and the bound CA(II) eluted using 
ammonium sulfate. Since this is a batch purification in each elution step the resin 
was washed with 1.5 times the resin volume using buffer B containing either 50, 
100, 200, 300, 400 or 500 mM ammonium sulfate via vacuum filtration.  A sample 
from each fraction was run on a SDS PAGE gel to analyze protein purity.  CA(II) 
eluted at ammonium sulfate concentrations between 200 and 400 mM.   The 
eluted CA(II) was dialyzed against buffer B to remove the ammonium sulfate 





 The concentration of CA(II) was determined by absorbance at 280 nm (ε = 
50,700 M-1cm-1) and the concentration of active CA(II) was determined by a 
stoichiometric titration of the fluorescence of the CA(II)-dansylamide (DNSA) 
complex with the tight binding ligand, diamox (acetazolamide, Sigma A6011).  
This method accurately measures the number of sulfonamide binding sites, 
reflecting CA(II) active sites [92].  The titration was carried out using 
concentrations CA(II) of 0.5 – 1 µM in 10 mM MOPS, pH 7.0 buffer containing 1-
2 µM ZnSO4. The excess zinc is present to ensure that all of the CA(II) in the 
sample is zinc bound.  The fluorescent sulfonamide DNSA is added to the protein 
solution. Intrinsically fluorescent residues in the protein (Tryptophan and 
Tyrosine) are excited at 290 nm [137].  The fluorescence emission from these 
residues at ~340 nm excite DNSA with an emission wavelength of 450 nm.   
Addition of a non-fluorescent competing ligand, Diamox, competes with DNSA for 
binding to CA(II) and decreases the observed FRET signal. Diamox is a non-
fluorescent sulfonamide that has a nanomolar affinity for holo-CA(II).   DNSA 
fluorescence as a function of added Diamox was measured. Under these 
conditions Diamox binding to CA(II) is essentially stoichiometric. Two linear fits 
were performed – the first line was fit to the initial fluorescence decrease (low 
Diamox concentrations) and the second line was fit to the plateau region (high 
Diamox concentrations). The intercept of the two linear fits yields the 




Dapoxyl sulfanomide synthesis (Optimized in collaboration with Da Wang): 
Ten milligrams dapoxyl sulfonyl chloride (Molecular Probes) was dissolved 
in 2 mL dry acetonitrile and placed in a 10 mL pre-dried reaction flask.  
Anhydrous ammonia gas was bubbled through a dry ice acetone-cooled cold-trap 
condenser.  Liquid ammonia was then slowly dripped into the flask containing the 
dissolved Dapoxyl sulfonyl chloride.  The reaction was allowed to stir on ice.  
Upon completion of the reaction, the mixture exhibits a color change from brown 
to yellow-green.  The flow of ammonia gas was stopped after 20 min.  Excess 
ammonia was evaporated by stirring for  ~45 min. To remove salt or unreacted 
contaminants, the mixture was filtered. The final product (dapoxyl sulfonamide) 
was dried using a SpeedVac® vacuum.  The dry powder was dissolved in 1.5 mL 
of a 1:1 mixture of methanol and acetonitrile.  The product was further purified by 
preparatory C18 reverse-phase HPLC (CH3CN/H2O-0.1% TFA, 5%-100% over 
60 min, 5 mL/min, 350 nm detection (tR=42 min)).  Dapoxyl sulfonamide was 
confirmed by thin layer chromatography, mass spectrometry (a single peak at 
344.0 Da), and fluorescence (emission spectrum peak at 535 nm when excited at 




















Figure 2:3:  Fluorescence spectrum of dapoxyl sulfonamide bound to 
CA(II): 
Emission spectrum (Ex = 365 nm) of 4 µM Dps in 10 mM MOPS, pH 7.0, 25°C in 
the presence of 1 µM WT CA(II) 
 
 
The excitation and emission spectra of the product of the Dps synthesis were 
similar to those previously published (Figure 2.3).  The final concentration of 
purified Dps was determined by measuring the absorbance at 365 nm (ε = 
22,000 M-1cm-1) [107].  
 
 
Measurement of CA(II) affinity for Dps: 
 The affinity of CA(II) for Dps was determined by monitoring the formation 
of the CA(II)-Dps complex from the increase in fluorescence (excitation = 280 nm 
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or 365 nm, emission 540 nm) upon stepwise addition of 0.2 µM Dps into a 
solution of 100 nm CA(II) in 10 mM MOPS (pH 7.0).  These concentrations were 
10-fold smaller than the reported Kd for Dps to holo-WT enzyme [130].  The 
fluorescence signal was measured 1-5 min after the addition of Dps.  Binding 
constants and error estimates were determined using the Kaleidagraph curve-
fitting program with Equation 2.1 when [Dps] < Kd or Equation 2.2 when [Dps] > 
Kd.  
    (Eq 2.1) 
 (Eq 2.2) 
 
 
Conjugation of thiol-reactive fluorophores to CA(II) variants: 
 The CA(II) variants containing a unique cysteine at position 67 were 
conjugated with Oregon Green 488 C2-Iodoacetamide (Molecular Probes: 
Catalog No. O-6010; Figure 2.4) for measurement of metal affinity. The thiol-
reactive Oregon Green dye and its conjugates exhibit bright fluorescence and 
have high photostability.   The N67C/C206S variant was labeled since this site is 














([CA]tot +[Dps]tot + KD ) " ([CA]tot +[Dps]tot + KD )







Figure 2:4:  Thiol reactive dye Oregon Green:  
The key advantages of this fluorescent dye 
include greater photostability, water 
solubility, brighter emission intensities and 








Before conjugation, the protein was thawed and dialyzed against 50 mM HEPES 
buffer pH 7.2 at 4 oC. The cysteine in CA(II) was reduced with 1 mM DTT or 
tris(2-carboxyethyl)phosphine (TCEP) for 3 h at 4 oC. Excess reductant was 
removed via dialysis against 50 mM HEPES buffer pH 7.2 at 4 oC overnight.  A 5-
fold molar excess of the fluorescent Oregon Green 488-iodoacetamide dissolved 
in DMF (dried with ammonium sulfate) was added to <100 µM reduced CA(II) 
and allowed to react for 1-2 h at room temperature. The volume of DMF used 
should not exceed by more than 5% of the total volume of the labeling reaction 
mixture to ensure that the protein is not denatured. The reaction was stopped by 
adding 10-fold molar excess of β- mercaptoethanol (BME) over Oregon Green 
488-iodoacetamide.  BME reacts with the iodoacetamide moiety in the 
fluorphores, but not the thioether linkage of the protein. To remove fluorophore 
 
 52 
that is not covalently attached, the labeled protein was dialyzed (100 mM bicine, 
pH 7.2) 2-3 times each for ~1-2 hours until the dialysate was colorless.  
Concentrations of the label and the protein were determined from absorbance at 
the peak fluorophore absorbance wavelength and extinction coefficient, as 
reported by Molecular Probes (see Table 2.2). The extent of labeling was 
estimated by comparison of the fluorophore concentration to the protein 
concentration, which was determined using the absorbance at 280 nm and the 







Absorbance Emission Extinction 
Coefficient 
Oregon Green 488 491  516  68,000 cm-1M-1 
 
Table 2.2: Spectral characteristics of selected reactive dye:  
This thiol-reactive dye is excited with visible light. The absorption (Abs) and 






Preparation of Apo-enzyme:   
 All plasticware and pipette tips used for preparation of metal free solutions 
and apo-protein was purchased as “metal free” (Bio-Rad) to minimize metal ion 
contamination.  All solutions were made using deionized, 18 MΩ water and were 
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stored in low metal, pre-treated plasticware.  Apo-CA(II) was prepared by 
overnight incubation with 25 mM dipicolinic acid (DPA) in 10 mM metal-free 
(chelexed) MOPS buffer, pH 7.0, followed by chromatography on a PD-10 
column (Sephadex G-25M, 5 cm X 15 cm, Pharmacia) pre-equilibrated with  
10 mM metal- free MOPS buffer, pH 7.0.  The resulting enzyme was 
concentrated using an Amicon Ultra concentrator (Millipore) and the protein 
concentration was determined from the absorbance at 280 nm using ε280= 
50,070 M-1cm-1 for all variants.  The bound zinc ion concentration was 
determined by ICP-MS.  Further studies were continued only if the metal: protein 
stoichiometry of the apo-enzyme was ≤ 0.1. 
 
 
Zinc affinity measurements:  
500 nM apo-CA(II) (with or without an extrinsic fluorophore attached) was 
incubated with Zn-NTA buffers that have a wide range of free zinc concentrations 
(chelexed 10 mM MOPS, pH 7.0, 1 mM nitrilotriacetic acid (NTA), 0 – 9.6 x 10-4 
M added ZnSO4, 0 - 5.1 x 10-8 M free zinc).  Total zinc content in each buffer was 
measured by ICP-MS.  Free metal concentrations in each buffer were calculated 
using the MINEQL+ software package (Environmental Research Software, 
Hallowell, ME) (Table 2.3).  CA(II) was equilibrated in the metal ion buffer at 25 
oC for 8 to 14 h.  Then, 4 µM Dps was added to the protein and buffer mixture 
followed by centrifugation at 20,000 xg for 5 min. The Dps fluorescence (Ex = 
340 nm, Em = 535 nm) was measured in a fluorimeter for each free zinc 
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concentration.  The protein concentration was also determined from A280.  During 
FRET analysis, the intrinsic protein fluorescence acts as a donor to the Dps 
inhibitor. The Dps fluorescence was then monitored as a function of the free zinc 
concentration.  A single binding isotherm (Eq 2.3) was fit to the data to determine 
the apparent zinc affinity of CA(II). 
   (Eq 2.3) 
                                                               
 
 [Zn], total M 
[Zn], Free 
M 2X [Zn], total M 
Bufffer #    
Control Control Control Control 
1 1.00E-09 2.13E-15 2.00E-09 
2 5.00E-09 1.06E-14 1.00E-08 
3 1.00E-07 2.13E-13 2.00E-07 
4 2.50E-07 5.32E-13 5.00E-07 
5 5.00E-07 1.06E-12 1.00E-06 
6 2.00E-06 4.26E-12 4.00E-06 
7 5.00E-06 1.07E-11 1.00E-05 
8 2.50E-05 5.46E-11 5.00E-05 
9 5.00E-05 1.12E-10 1.00E-04 
10 2.00E-04 5.32E-10 4.00E-04 
11 5.00E-04 2.13E-09 1.00E-03 
12 7.50E-04 6.39E-09 1.50E-03 
13 9.00E-04 1.92E-08 1.80E-03 
14 9.60E-04 5.10E-08 1.92E-03 
 
Table 2.3:  Zinc (II) Metal Buffer Series:  
This is a set of free zinc (II) calibration buffers made with MOPS as the pH buffer 
and NTA as the metal ion buffer.  The final free zinc concentrations in 2 mM 
NTA, 10 mM MOPS buffer, pH 7.0, 25 oC is µM-pM.  Note: This is a 2X buffer: 































Copper affinity measurement: 
The CA(II) variants containing the N67C/C206S substitutions (50 nM) 
were labeled with Oregon Green and the apo-enzyme prepared as described 
above. Stoichiometric Cu(II) binding to Oregon Green-labeled CA(II) results in an 
85% decrease in fluorescence intensity; this decrease in fluorescence was used 
to monitor the copper affinity. Green labeled CA(II) (0.5 µM) was incubated with 
Cu(II)-NTA buffers in 10 mM MOPS, pH 7.0, at room temperature.   The free 
metal concentrations were calculated using the MINEQL+ software package 
(Environmental Research Software, Hallowell, ME)  (see Table 2.4).  Following 
equilibration at 25 °C, the Oregon Green 488 fluorescence (Ex = 491 nm, Em = 
516 nm) intensity was monitored in a fluorimeter as a function of the free copper 
concentration. A single binding isotherm (Eq 2.4) was fit to the data to determine 
the apparent copper affinity of CA(II). 
                                                                                                                                 (Eq 2.4) 
 










































2X [Cu] total, 
M 
Buffer #:      
0 Control Control Control 
1 3.76E-15 5.00E-07 1.00E-06 
2 7.52E-15 1.00E-06 2.00E-06 
3 1.88E-14 2.50E-06 5.00E-06 
4 3.78E-14 5.00E-06 1.00E-05 
5 5.68E-14 7.50E-06 1.50E-05 
6 7.59E-14 1.00E-05 2.00E-05 
7 1.93E-13 2.50E-05 5.00E-05 
8 3.96E-13 5.00E-05 1.00E-04 
9 6.10E-13 7.50E-05 1.50E-04 
10 8.36E-13 1.00E-04 2.00E-04 
11 1.07E-12 1.25E-04 2.50E-04 
12 2.51E-12 2.50E-04 5.00E-04 
13 4.52E-12 3.75E-04 7.50E-04 
14 7.54E-12 5.00E-04 1.00E-03 
15 1.26E-11 6.25E-04 1.25E-03 
16 2.26E-11 7.50E-04 1.50E-03 
17 4.28E-11 8.50E-04 1.70E-03 
 
Table 2.4:  Copper (II) Metal Buffer Series:  
This is a set of free copper (II) calibration buffers made with MOPS as the pH 
buffer and NTA as the metal ion buffer.  The final free copper concentrations in 2 
mM NTA, 10 mM MOPS buffer, pH 7.0, 25oC is fM-pM.  Note: This is a 2X 









Sulfonamide inhibitors bind to CA(II) by coordinating to the zinc ion at the 
active site, replacing the metal water ligand.  For many fluorescent aryl 
sulfonamides, including dapoxyl sulfonamide (Dps), binding to CA(II) leads to a 
significant increase and a blue shift in the fluorescence emission.  Therefore, Dps 
binding to CA(II) can be monitored by changes in fluorescence (excitation = 365 
nm, emission 540 nm). 
Using the characteristic fluorescent intensity changes upon Dps binding to 
holo-enzyme, the affinity of the second shell variants of CA(II) for Dps (Figure 
2.5) has been determined.  In particular, mutations at T199 could alter the Dps 
affinity since crystal structures suggest a hydrogen bond between Dps and the 
hydroxyl of T199.  A single binding isotherm was fit to the data for Dps binding to 
N67C/TI99N/C206S CA(II) and N67C/TI99G/C206S CA(II), but the quadratic 
form of the single binding isotherm yielded the best fit of the N67C/TI99V/C206S 
and N67C/TI99I/C206S data due to the high affinity.  The results of those fits are 
shown in Table 2.5. The affinity of the N67C/C206S CA(II) variant is comparable 
to that of WT CA(II) implying that these mutations do not affect sulfonamide 
affinity. In this set of experiments, “WT” data  refer to N67C/C206S CA(II). 
Furthermore, the TI99V/N67C/C206S and TI99I/N67C/C206S variants have an 
affinity for Dps that is comparable to “WT” CA(II), suggesting that a hydrogen 
bond with T199 is not necessary for high Dps affinity. However, substitution of 
T199 with glycine (T199G/N67C/C206S) or asparagine (T199N/ N67C/C206S) in 
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Figure 2:5:  Dps affinity studies of 2nd shell mutants:  
The measured affinities of protein for Dps as determined in 10 mM MOPS pH 
7.0, 0.1 mM ZnSO4, 100 nM CA(II) at room temperature. (): T199G; (): 



















Protein KDDps, µM Effect 
N67C/C206S_CA(II) 0.21 ± 0.01  
T199G CA(II) 1.4 ± 0.09 7-fold weaker 
T199I CA(II) 0.27 ± 0.01 Negligible 
T199N CA(II) 7.2 ± 0.8 35-fold weaker 
T199V CA(II) 0.35 ± 0.03 Negligible 
 
Table 2.5:  Dps affinity measurements of selected second shell variants:  
The measured affinities of protein for Dps as determined in 10 mM MOPS, pH 
7.0, 0.1 mM ZnSO4, 25 °C. All of the listed mutations were made in human CA(II) 
and also contain the N67C and C206S mutations 
 
 
The nature of the direct ligands and the structure of the hydrogen bond 
network are important for optimizing the metal affinity of CA(II) [58]. The 
hydrogen bond between the protein and the zinc ligands are proposed to orient 
the ligands in a tetrahedral geometry for optimal zinc coordination.  Since Cu2+ 
binds to CA(II) with trigonal biypyramidal geometry with 2 coordinating water 
molecules, the second shell ligands are proposed to enhance the affinity of Zn2+ 
relative to Cu2+.  In particular, hydrogen binds to the zinc water ligand are 
hypothesized to influence Zn/Cu selectivity.  The replacement of Thr199 with 
amino acids capable of forming a hydrogen bond with the zinc-water ligand is 
predicted to maintain high zinc affinity, while deletion of this hydrogen bond is 
predicted to decrease zinc affinity.  On the other hand, mutations at Thr199 that 
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stabilize the metal coordination of multiple water molecules, perhaps by 
increasing the volume around the metal site, are predicted to enhance the copper 
affinity.  
To test the importance of the second shell ligands in determining the Zn2+/ 
Cu2+ selectivity, the following mutants were prepared using Quik-Change 
mutagenesis and characterized: T199A, T199G, T199I, T199N, T199S, T199V, 
Q92A, and Q92L.  To measure the Zn2+ affinity, first apo-enzyme was prepared 
via dialysis against DPA. For all of the mutants, apo-enzyme was easily prepared 
using methods developed for the wild-type enzyme suggesting that the mutants 
do not bind Zn2+ significantly more tightly than WT CA(II)..  The Zn2+-bound 
CA(II) can be detected directly from the changes in fluorescence intensity upon 
binding Dps.  However, the accuracy of the measurement increases by using a 
ratiometric method.  Therefore, the fraction of CA(II) with bound Zn2+ was 
determined from FRET between Dps and the tryptophan and tyrosine residues in 
CA(II). 
The Zn2+ affinity of CA(II) variants was evaluated by incubating apo-CA(II) 
with varying concentrations of free Zn2+ maintained using zinc-NTA buffers.  The 
presence of metal-binding ligands together with zinc contamination from many 
sources generally makes it challenging to reproducibly prepare solutions with low 
concentrations of free zinc by simple addition of small amounts of zinc to ordinary 
pH buffers.  For this reason we prepare zinc ion ‘‘buffers’’ to maintain fixed low 
zinc ion concentrations in a solution. These buffers contain moderate 
concentrations of zinc (mM) and a fairly tight-binding ligand, nitrilo-triacetic acid 
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(NTA).  NTA chelates the majority of the zinc, and this composition resists 
elevation of the free zinc concentration if contaminating zinc is present [138].  
The zinc-bound CA(II) at each zinc concentration was detected by the addition of 
Dps and measurement of the Dps fluorescence intensity (540 nm) ratioed to the 
concentration of the protein in each sample (Figure 2.6).  A single binding 
isotherm was fit to these data and the calculated Kd,Zn values are listed in Table 
2.6.  The N67C/C206S mutations have little effect on the zinc affinity of CA(II).  
However, mutations in the second shell ligands at Q92 and T199 uniformly 
decrease the zinc affinity.  Mutations at T199 have more variable effects on zinc 
affinity.  In this case, the side chains that retain a group that can form a hydrogen 
bond (Asn and Ser) result in smaller decreases in affinity than side chains that 
cannot form hydrogen bonds (Gly, Val, Ile).  The T199V mutation has the largest 



























































Figure 2:6: Zinc (II) affinity studies of second shell variants:  
The fluorescence of 500 nM apo-CA(II)_Q92 and T199 mutants in 10 mM MOPS 
zinc-NTA buffers, pH 7.0, 4 mM Dps,  with varying concentrations of free zinc at 
25 oC. The FRET emission  (Ex = 290 nm, Em =  535 nm) was ratioed to the 
intrinsic protein fluorescence emission ( Ex = 290 nm, Em =  340 nm). A single 
binding isotherm (Eq 2.3) was fit to the data and the values for KDZn are listed in 
table 2.4. The FRET intensity ratio increases with zinc concentration as the 
fraction of zinc-bound CA(II) increases, producing a binding curve with picomolar 
affinity. A) () Q92L, () Q92A; B) () T199S, () T199N, () T199I; C) () 



























































 To evaluate the role of second shell ligands in determining the Zn2+/Cu2+ 
selectivity, we altered the size and hydrophobicity of the amino acids at positions 
92 and 199 and measured the effect of these mutations on copper affinity. The 
copper affinity was monitored by quenching of a fluorophore conjugated to a 
single cysteine residue at position 67 (N67C/C206S) on the enzyme. Labeling 
efficiencies varied between 20-77% (data not shown). Oregon Green 488 was 
chosen as an optimal label for copper (II) determination due to its high extinction 
coefficient, quantum yield and photostability.  Because the Oregon Green has 
high extinction coefficients and quantum yields, a measurable signal output upon 
metal binding was observable even at the low protein concentrations used for 
these measurements. Furthermore, copper binding significantly quenched (up to 
70%) the fluorescence of Oregon Green conjugated to the Q92A and T199 
mutants (Figure 2.7) 
Fluorescently labeled apo-CA(II) was incubated with various 
concentrations of free Cu2+ maintained using MOPS, NTA-buffers, pH 7.0.  The 
fluorescence Oregon Green (excitation = 496 nm, emission 524 nm) was 
measured at the various Cu2+ concentrations and the signal plotted against free 
Cu2+ in each sample.  A single binding isotherm was fit to the data. 
The second shell mutations have a modest effect on Cu2+ affinity.  
Substitution at Q92, which forms a hydrogen bond with the His-94 zinc ligand, 
has little affect on the copper affinity.  Alterations in at T199 either cause little 
affect on Cu2+ affinity (TI99S, I, and N) or decrease affinity up to 3-fold (T199G 
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and T199V) (Figure 2.8).  Therefore, the second shell hydrogen bonds are less 
important for the affinity of CA(II) for Cu2+ than for Zn2+ and suggest that these 
side chains do not form energetically important hydrogen bonds with the copper-





























Figure 2:7:  Fluorescence intensity of 100  nM-Oregon Green labeled  
WT-CA(II) as a function of free Cu2+:  
The fluorescence of 50 nM apo-OG-CA(II)_N67C/C206S in 10 mM MOPS 
copper-NTA buffers, pH 7.0 was monitored  (Ex= 491 nm; Em= 520 nm). The 
wild-type enzyme binds copper more tightly than zinc with a Kd of 10 ± 2 fM.  










































































































































Figure 2:8: Fluorescence intensity of 100 nM-Oregon Green labeled T19and 
Q92 variants as a function of free Cu2+:  
The fluorescence of 100 nM apo-OG-CA(II)_Q92 and T199 mutants in 10 mM 
MOPS copper-NTA buffers, pH 7.0,  with varying concentrations of free copper at 
25 °C. Oregon Green emission is measured (Ex = 491 nm, Em =  516 nm).  A 
single binding isotherm (Eq 2.4) was fit to the data and the values of KDapp are 
listed in table 2.4. Quenching of the covalently attached fluorophore upon copper 
binding is more than >70%. A) () Q92A, () Q92L; B) () T199G, () T199N, 
































































 0.8 ± .1 
67 
 
Q92A 0.01 ± 0.002 17 ± 4 1700  
Q92L 
 0.012 ± 0.002 28 ± 16 2333 
T199G 
 0.052 ± 0.028 




































To demonstrate the utility of Dps as the donating fluorophore in our metal 
specificity studies, we first determined the binding affinity of the CA(II) mutants 
for Dps (Table 2.1). Amino acid substitutions at position 199 affect the binding of 
Dps differentially.  These data suggest that the dissociation constants for Dps are 
related to the hydrophobicity of the active site cavity, rather than the ability of the 
side chain at T199 to form a hydrogen bond with Dps.  Although these mutations 
decrease the Dps affinity compared to that of “WT” CA(II), changes in the Dps 
fluorescence can still be used to monitor zinc binding to CA(II). 
 To delineate the essential structural features that lead to Zn2+/ Cu2+ 
specificity, we altered the size and hydrophobicity of the amino acids at positions 
92 and 199 that form hydrogen bonds with the His94 and H2O zinc ligand, 
respectively. The following section discusses the zinc and copper affinity of these 
CA(II) variants and their interactions with the zinc-water ligand. 
T199A-The crystal structure of wild type CA(II) shows that the hydroxyl 
oxygen of T199 accepts a hydrogen bond from the zinc-bound water, one of the 
four direct zinc ligands [133].  A second hydrogen bond is formed between the 
hydroxyl hydrogen of T199 and a carboxylate oxygen of Glu-106.  In previous 
work, mutation of T199 to Ala decreased the zinc affinity decreased by an order 
of magnitude [66] .  Ippolito et al. have previously used X-ray crystallography to 
evaluate the T199A mutant structure [61].  These data show that the overall 
structure of this mutant is very similar to WT CA(II), however, the position of the 
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zinc-bound water shifts which allows the formation of a hydrogen bond with Glu-
106 [139]. 
T199V-Substitution of valine for threonine at position 199 decreases the 
affinity for Zn2+ almost 75-fold compared to wild type CA(II).  One interpretation of 
the decrease in affinity is that the hydrogen bond with the zinc-water ligand 
significantly stabilizes the bound metal ion.  However, the crystal structure of 
T199V CA(II) indicates that Glu-106, which hydrogen bonds with the T199 side 
chain in WT, forms a novel hydrogen bond to the zinc ligand, His-96 [140].  
Furthermore, the pKa of the zinc-bound water increases to 8.7.  Zinc affinity of 
WT CA(II) is dependent on pH due to the differential pKa values of zinc-bound 
water in solution Zn-H2O pKa ~9-10) and bound to CA(II) (pKa=6.8).  Therefore, 
the observed decrease in Zn2+ affinity may be related to this change in pKa.  The 
pKa of Cu2+-bound water in CA(II) is unknown but is likely higher than Zn2+ due to 
the increased number of ligands.  Therefore, effects on the pKa of the metal-
water ligand could lead to the observed alterations in the Zn2+/ Cu2+ selectivity for 
the T199V variant.  
T199G-Substitution of glycine for threonine at position 199 decreases the 
affinity for zinc almost 50-fold compared to wild type CA(II). The structure of 
copper bound to CA(II) demonstrates that copper forms a trigonal bipyramidal 
geometry common to copper binding sites by coordination of two water 
molecules.  This mutation was proposed to stabilize the metal coordination of 
multiple water molecules, perhaps by the increased volume around the metal 
site.   Contrary to our prediction, copper affinity was not enhanced in the glycine 
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mutant, indicating that deletion of the Thr side chain modestly destabilizes, rather 
than stabilizes, Cu2+-bound CAII. 
T199I-Similar to T199G and T199V, substitution of isoleucine for threonine 
at position 199 decreases the affinity for zinc almost 50-fold compared to wild 
type CA(II).  The observed decrease in Zn2+ affinity may be similarly related to an 
increase in the pKa of the bound Zn-H2O. 
T199S and T199N-The T199S and T199N mutations retain a group that is 
capable of forming a hydrogen bond with the metal-water ligand.  Both of these 
substitutions decrease zinc affinity (10-20-fold) but the decreases are smaller 
than those observed for mutations that cannot form hydrogen bonds.  This 
observation is consistent with the suggestion that this hydrogen bond stabilizes 
zinc affinity.  Copper binding affinities for these mutants are unchanged. 
The the carboxamide side chain of Q92 is a hydrogen bond acceptor for 
the protonated nitrogen atom in the imidazole ring of H94. .Characterization of 
mutations at this residue allows evaluation of the role of second shell ligands in 
determining Zn2+/Cu2+ selectivity.  Structures of these mutants demonstrate that 
the hydrogen bond between zinc-bound hydroxide and the side chain of T199 is 
maintained and that zinc-protein ligand coordination distances do not differ 
significantly from those of wild type CA(II) [65].   
 Q92A and Q92L-Removal of the side chain that functions as a hydrogen 
bond acceptor for the His-94 zinc ligand and replacement by a hydrogen bond 
with a solvent molecule in the Q92A mutant decreases zinc affinity 20-fold.  In 
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the variant Q92L the zinc affinity is decreased by 35-fold.  The electron density 
map of Q92L CA(II) shows that a solvent  molecule cannot be recruited to  
form a hydrogen bond to H94 [141].  These data demonstrate that the second 
shell ligand stabilizes zinc affinity, perhaps by orienting the His side chain in the 
apo-enzyme to the tetrahedral geometry observed in the zinc-bound enzyme. 
Copper (II) binds to CA(II) with trigonal bypyramidal geometry, suggesting that 
removal of a hydrogen bond might increase selectivity for copper relative to zinc.  
Indeed, our metal affinity measurements show modest effects on the copper 
affinity but zinc affinity is decreased 35-fold, leading to a change in the Zn2+/Cu2+ 


















The indirect ligands in metalloenzymes have been proposed to orient the 
ligands for optimal metal coordination based on a few key design characteristics:  
structure, composition and binding site environment.  To examine the molecular 
determinants of the metal ion specificity, we measured the Zn2+/Cu2+ binding 
ratios of 7 CA(II) mutants that differ with respect to the size and hydrophobicity at 
the positions 92 and 199.  The general trend is that any change in the indirect 
ligands for the wild type polyhedron decreases metal ion affinity overall, but 
reduces Zn2+ affinity much more than the affinity for Cu2+. The largest 
perturbations in the Zn2+/Cu2+ ratio are observed for the Q92L and T199I variants 
where decreased zinc affinities relative to stabilized copper affinities increase the 
KZn/KCu by 30-f and 47-fold, respectively.  One important success of this work 
was the development of a series of CA(II) variants with significantly improved 
properties for sensing copper in the presence of zinc. 
 One hypothesis for altering metal specificity is that the size of the metal 
ion binding site can influence the metal selectivity.  The larger site “should” favor 
the binding of a large ion over that of a small ion.  In addition, larger binding sites 
might stabilize the binding of metal-water ligands.  However, as seen in Table 2.6 
the size of the substituted side chain at position 199 does not influence the 
binding selectivity for Zn2+ versus Cu2+. Nonetheless, the effect of mutations to 
the second shell ligands on metal binding is large and variable, suggesting that 
the second shell ligands play varied roles, including orientation  of direct ligands 
and electrostatic effects transmitted through the direct ligands [106].  A clear 
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trend is presented suggesting that hydrogen bonding to second shell ligands 
influences metal ion selectivity in CA(II) by specifically enhancing zinc affinity.  
These data, support the proposal that the geometry of the direct ligands in the 
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CHAPTER 3: Tuning Metal Sensitivity and Ratiometric Change with 





The physiological importance of Zn2+ demands that cells maintain control 
over the homeostasis of this metal ion.  Although most of the intracellular Zn2+ is 
tightly bound, serving as a structural and catalytic cofactor for a number of 
cellular proteins, it is ubiquitous among the compartments of the cell [58].  Well- 
studied examples of the role of zinc in a number of human disorders and 
biochemical pathways have been outlined in the introduction of this work (see 
Chapter 1). Despite the acceptance of these phenomena, the mechanistic details 
surrounding intracellular Zn2+ storage, transport and function are poorly defined 
even in the simplest of organisms [142].   Several families of fluorescent Zn2+ 
probes have been designed to address the need to understand the spatial and 
temporal distribution of ionic zinc pools in living cells [143], [40].  However, these 
sensors typically lack selectivity between the cytosol and subcellular 
compartments.  More importantly, these probes are limited in their ability to 
detect free Zn2+ concentrations below the nanomolar range [144],[145]. Likewise, 
the TAT-tag mediated delivery of ratiometric CA(II) sensors, which has been 
successfully applied to mammalian cell lines to detect pM levels of readily 
exchangeable zinc, cannot be taken up by other organisms in the cell without 
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detrimental effects.  Also, the chemical labeling of this isolated protein with the 
AlexaFluor fluorophore is tedious, labor intensive, and does not always proceed 
in high yield.   Until recently, genetically encoded fluorescence based sensor 
proteins with higher binding affinity and full cell compatibility remained 
underdeveloped.  Vinkenborg et al developed a FRET- based sensor that can 
ratiometrically monitor intercellular zinc fluctuations in the cytosol and subcellular 
organelles [146]. 
 Here we describe an advancement in CA(II)-based zinc sensing that can be 
readily expressed in cells. The expressible sensor is constructed by fusing a 
fluorescent protein to CA(II) as a fluorescence acceptor and using a zinc-
dependent FRET donor, dapoxyl sulfonamide; as used in our earlier generation 
sensors. The relatively small size of the fluorescent protein variants and CA(II) 
means that efficient energy transfer between the dapoxyl sulfonamide and the 
fluorescent protein acceptor is feasible. An ideal candidate fluorescent protein for 
an expressible CA(II) sensor should meet the following criteria: excitation 
spectrum overlaps with the emission of dapoxyl sulfonamide to ensure good 
FRET efficiency, high extinction coefficient and quantum yield, fast maturation, 
and monomeric state. Fluorescent proteins have been applied successfully as 
non-invasive labels to study protein localization, dynamics and interactions in 
living cells[48]. 
 The first and most studied of this class is the Green Fluorescent Protein 
(GFP) that was originally isolated from the hydroid jellyfish Aequorea Victoria 
[147]. The fluorophore of GFP resides within an 11- stranded β-barrel and is 
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formed autocatalytically by spontaneous cyclization of three amino acids; serine, 
tyrosine and glycine [148]. Mutagenesis of GFP has generated a variety of 
fluorescent proteins with shifted wavelengths of excitation and emission, ranging 
from blue to red [149]. Besides mutations that affect the spectral properties, 
numerous modifications have been described that improve the photophysical 
properties, environmental stabilities and protein folding properties [150], [151].  
Directed evolution studies have generated a large pool of fluorescent proteins 
that can be used for this purpose, such as variants of RFPs from Discosoma sp. 
and Entacmaea quadricolor [127]. This great work creating fluorescent proteins 
with far red shifted excitation and emission profiles that reduce the problem of 
autofluorescence making them more suitable for imaging in whole tissues or 
organisms has recently been published [152].  Furthermore, fluorescent proteins 
with different spectra can be coupled to CA variants with different zinc affinities, 
thus creating a multicolor measurement covering a wide dynamic range in a 
single experiment. This chapter illustrates our initial experiments to prepare and 












MATERIAL AND METHODS 
 
DNA Cloning and Mutagenesis: 
Bacterial Vector Design: 
The construction of the fusion proteins of CA(II) and mCherry and 
mOrange used the pACA1 vector, encoding CA and the pRSET-B vector (Figure 















Figure 3:1:  Map of pRSET-B:  
The pRSET vectors are pUC-derived expression vectors designed for high-level 
protein expression and purification of cloned genes in E. coli. High levels of 
expression of genes cloned into the pRSET vectors are made possible by the 





the starting template [134]. The Tsien group of the Howard Hughes Medical 
Institute at the University of California, San Diego (UCSD) donated the mCherry 
and mOrange plasmids. Extension of overlapping gene segments by PCR is a 
simple, versatile technique for site-directed mutagenesis. Initial PCRʼs generate 
overlapping gene segments that are then used as template DNA for another PCR 
to create a full-length product. Internal primers generate overlapping, 
complementary 3' ends on the intermediate segments and introduce nucleotide 
substitutions, insertions or deletions for site-directed mutagenesis, encode the 
nucleotides found at the junction of adjoining gene segments [153]. Overlapping 
strands of these intermediate products hybridize at this overlapping region in a 
subsequent PCR and are extended to generate the full-length product that can 
include restriction enzyme sites for inserting the product into an expression 
vector for cloning purposes.  
To construct a vector encoding the CA_mCherry and CA_mOrange fusion 
proteins, PCR-amplified fragments encoding each individual protein were 










Primer Sequence (5’------> 3’) 
A 
 
GAA ATA ATT TTG TTT AAC TTT AAG AAG GAG ATA TAC CAT GG 
B 
 
CTC CTC GCC CTT GCT CAC TCC GCC ACC TTT GAA GGA AGC 
C GCT TCC TTC AAA GGT GGC GGA GTG AGC AAG GGC GAG GAG 
D GTC TCC TTT CGG GCT TTG TTA GCA GCC GGA TCA AGC TT 
Table 3.1:  Overlap Extension PCR PrimersTable  
 
 
The sequence between CA(II) and mCherry(mOrange) is a three glycine (GGG) 
linker.  In this method, first the CA(II) gene is amplified using a 3’ primer that 
extends the 3’ end of the gene and, separately, the mCherry gene is amplified 
using a 5’ primer that adds the complementary sequence to the 5’ end of this 
gene.  Secondly, the two fragments are mixed, denatured and re-annealed.  In 
the absence of added primers, the complementary region of the two fragments 
act as primers forming a full-length fusion gene (Figure 3.2).  In the next step, the 





Figure 3:2:  Fusion of CA(II) (brown) and mCherry (pink) sequences by 
overlap extension PCR:  
The CA(II) region is amplified with primers A and B, and the mCherry region is 
amplified with primers C and D. Primers B and C are reverse complementary and 
are specific to the part of the fused region encoding the GGG-linker. When mixed 
together, the PCR products will hybridize and extend from the overlap site. The 
fusion product is amplified from primers A and D 
 
 
5’ end of CA and the 3’ end of mCherry.  These primers also included the 
following restriction sites: Nco1 (5’ end of CA(II)) and HindIII (3’ ends of the 
fluorescent proteins. 
Finally, the DNA product encoding the CA_mCherry  and CA_mOrange 
fusion protein, was PCR amplified for further optimization using TOPO Cloning 
Technology (Invitrogen, Life Technologies).  Ligation of our fusion products into a 
multiple cloning vector allows us to manipulate our fusion product with higher 
 
 85 
efficiency introduced. The CA_mCherry and CA_mOrange fragments were 
ligated into the TOPO vector at  the Nco1 and HindIII restrictions sites.  Finally, 
the DNA encoding the CA(II)_FP were PCR amplified using 
GGGGAATTCATGGCCCATCACTGGGGGTA primers as a forward and 
GGGCTCGAGTCTTGTACAGCTCGTCCATGCC as a reverse primer, hereby 
introducing EcoR1 at the 5’ end and Xho1 3’ end along the gene via Zero Blunt® 
TOPO® PCR Cloning.  The modified gene of the CA_mCherry protein was 
completely removed from the TOPO vector with alkaline phosphatase,CIP (from 
NEB, Beverly, MA). Calf intestinal alkaline phosphatase catalyzes the removal of 
the 5’ phosphate from DNA, thus restricting re-ligation of the vector alone.   A 
compatible modified CA_mOrange fragment was generated by digestion of the 
CA_mOrange TOPO vector with the same restriction enzymes. Resulting, 
CA_mOrange and CA_mCherry fragments were purified by separation on an 
agarose gel prepared with Molecular Biology grade agarose (Bio-Rad) and 
electrophoresed in modified TAE buffer (40 mM TRIS-acetate, 0.1 mM EDTA, pH 
8.0). The appropriate bands were excised from the gel and the DNA was 
recovered using the Montage DNA Gel Extraction Kit (Millipore). The 
concentration of the DNA recovered from the gel was generally low ng/µL 
concentrations. 
Ligation reactions of the fusion products, encoding the EcoR1 and Xho1 
restriction sites, into the bacterial vectors pET23a and pET20b were performed in 
1X T4 DNA ligase buffer (50 mM Tris-HCl, 10 mM MgCl2, 10 mM Dithiothreitol 1 
mM ATP, pH 7.5 @ 25°C. Supplied as a 10X concentrated stock) using 5 µL of 
 
 86 
vector, 5 µL of insert DNA and 1 µL of T4 DNA Ligase (NEB) in a total volume of 
50 µL. Vector-only control ligations were also prepared. The ligation mixes were 
incubated overnight on ice.  The following day, 5 µL of the ligation mix was 
transformed into 50 µL of chemically competent SmartCells following the protocol 
provided (Open Biosystems, Huntsville, AL).  This protocol calls for mixing the 
ligation mix and the competent cells on ice for 15 min, followed by 45 s at 42°C.  
The heat shocked cells were added to 250 µL of media SOC media and 
incubated at 37°C for 1 h in an air incubator.   All of the transformed cells were 
plated out onto LB-agar plates with 100 µg/mL ampicillin and incubated at 37°C 
overnight. Vector re-ligation was determined from the number of colonies 
observed on the vector only control plates and all samples showed more colonies 
on the vector plus insert plates.  Unfortunately, the number of colonies were not 
estimated and documented. Single colonies from the vector plus insert plate 
were used to inoculate 50 mL LB-amp liquid cultures, and grown overnight at 
37°C. The plasmid DNA was isolated using the Qiagen Hi-Speed Midi Plasmid 
Kit and the purified plasmids were submitted for DNA sequencing. The resulting 
DNA construct encoding CA_mOrange and CA_mCherry, named p23aCA_mO 
or p23aCA_mC p20bCA_mO or p20bCA_mC contains a T7 promoter for over-
expression and the linker inserted between CA(II) and mCherry (Table 3.2).  The 
map of the CA(II)_mCherry fusion protein are shown in Figures 3.3-3.4.  
In efforts to further optimize this sensor technology, a third bacterial 
vector, pET24a encoding CA_mCherry was generated by Da Wang (Fierke Lab).  
The protein was digested from the pAH_CA_mCh vector and PCR amplified. The 
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amplified CA_mCherry gene was inserted in the BamH1 and Xho I sites of the 
pET24a vector, generating p24aHCA_mCh.  Because the TAT tag is upstream of 
BamHI it was not included in the final fusion product.  This plasmid contains a 

















Figure 3:3:  Map of pET23A_mCherry:  
CA(II)_mCherry was inserted into the pET23a vector between the EcoRI and 
Xho1 sites. “3G” represents the tri-glycine linker. The plasmid is expressed under 








Vector Name Encoded Protein Linker Sequence Parent Vector Mutations 
pACA1a CA(II)   Xho1 site added 5’-CTCGAG-3’ 
pRSET-Bb mCherry/mOrange    
p23a_CA_mChc CA(II)_mCherry GGG pACA1 and  pRSET-B 
EcoR1 site added 
5’-GAATTC-3’ 
Xho1 site added 
pAHT_CA_mChd CA(II)_mCherry GGG pAHT1 and  p23a_CA_mCh 
N-termini HIS6 removed  
C-termini HIS6 added 
p20b_CA_mChc CA(II)_mCherry GGG pACA1 and  pRSET-B 
EcoR1 site added 
Xho1 site added  
p24aH_CA_mChe CA(II)_mCherry GGG pAHT_CA_mCh  
pRS316-CA_mCc CA(II)_mCherry GGG pACA1 and  pRSET-B 
Sal1 site added 
5’-GTCGAC-3’ 
Not1 site added 
5’-GCGGCCGC-3’ 
Table 3.2:  Summary of CA(II) and fluorescent protein vectors:  
Summary of vectors used and constructed including the vector name, the 
encoded protein, linker sequence (if applicable), the parent vector and any 
mutations made. CA(II)_mOrange versions of these plasmids were also 
constructed. [a – from 16; b – Donated by the Tsien group; c – constructed by 






Mammalian vector design: 
A TAT_CA_mCherry gene was generated using overlap extension using 
pAHT1 encoding His6-TAT-wtCA in pACA1 and the p23a_CA_mCh plasmid 
encoding CA_mCherry under the control of a T7 promoter, were used as the 
starting templates. The resulting fusion product, mCherry fused to the 3’ end (C-
termini) of CA(II) by a three glycine linker was re-ligated into the pET23a vector 
at the EcoRI and XhoI sites, creating pAHT_CA_mCh. The HIS-6 tag on the N-
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termini was removed and added to the C-termini end by QuikChange 
mutagenesis (Stratagene) (Figure 3.5). 
 
Eucharyotic vector design: 
For expression of CA(II)_mCherry and CA(II)_mOrange in S. cerevisiae, 
the fused gene containing the tri-glycine linker was PCR amplified from the 
TOPO vector using primers complimentary to the 5’ end of CA and the 3’ end of 
mCherry.  These primers also included the following restriction sites: Sal1 (5’ end 
of CA(II)) and Not1 (3’ ends of the fluorescent proteins). Both mutations were 
introduced at the same time using the quickchange multi-site directed 
mutagenesis kit (stratagene) with forward and reverse primers 
GGGGTCGACATGGCCCATCACTGGGGGTA and 
GGCGGCGGCCGCTTACTTGTACAGCTCGTCCATG, respectively.  All 
restriction site changes were confirmed either by restriction enzyme digestion 
and/or DNA sequencing.  The molecular biology protocols used to subclone the 
digested product encoding the fusion protein linked by a tri-glycine sequence into 
the Sal1 and Not1 sites of pRS316 are the same as those detailed for the 
construction of the bacterial vectors.  The resulting vectors were named 
pRS316_CA_mCh and pRS316_CA_mO (Table). The fusion proteins can be 
expressed in yeast strains DY1457 and ZHY1 (provided by David Eide, 
University of Missouri) by induction with galactose (Figure 3.6).  The in vivo 
concentration of the fusion protein can be estimated from the fluorescence of 





















Figure 3:4:  Map of pET24A_CA(II)_mCherry:  
CA(II)_mCherry was inserted into the pET24a vector between the BamH1 and 
Xho1 sites. “3G” represents the tri-glycine linker. The plasmid is expressed under 
the control of the T7 promoter and is an Ampicillin-resistance gene. The plasmid 










































Figure 3:5:  Map of pET23a_TAT_CA(II)_mCherry:  
CA(II)_mCherry was inserted into the pET23a vector between the EcoR1 and 
Xho1 sites. “3G” represents the tri-glycine linker. The plasmid is expressed under 
the control of the T7 promoter and is an Ampicillin-resistance gene. The plasmid 















































Figure 3:6:  Map of pRS316_CA(II)_mCherry:  
CA(II)_mCherry was inserted into the pRS316 yeast vector between the Sal1 and 
Not1 sites. “3G” represents the tri-glycine linker. The plasmid is expressed under 




Protein expression and purification in E. coli: 
 The protocol used for recombinant expression of the CA(II)-fluorescent 
protein fusion in bacterial cells is modified from the methods used to overexpress 
CA(II) [154], and used to purify the CA(II) only proteins. Chemically competent 
BL21(DE3) E. coli were transformed with the appropriate plasmid encoding HIS-
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tagged CA(II)_FP fusion and grown overnight on LB ampicillin agar plates. A 
single colony was selected from the LB-amp plates and grown overnight at 37°C 
in liquid 2XYT-amp culture.  The cells were diluted 1:200 in 2XYT, grown at 37°C 
until OD600= 0.7-0.75 and protein induced by the addition of 1 mM isopropyl β-D-
thiogalactopyranoside (IPTG).  After 6 h of incubation at 25°C, the cells were 
harvested by centrifugation at 4°C for 15 min at 6,000 xg. The cell pellet was 
resuspended in 10 mL per liter of culture of cold 50 mM TRIS-SO4 pH 8.0, 50 mM 
NaCl, 200 µM ZnSO4, 1 mM dithiothreitol (DTT), 10 µg/mL PMSF and 1 µg/mL 
TAME prior to flash freezing. 
After thawing, the cells were lyzed using a microfluidizer and the cellular 
debris removed by centrifugation (45 min, 10,000 xg). A 1.0% streptomycin 
sulfate precipitation was performed and the debris removed by centrifugation (30 
minutes, 10,000 xg). The resulting protein solution was dialyzed against buffer  
(30 mM Hepes, pH 8.0, 150 mM NaCl) in preparation for nickel affinity batch 
chromatography. Nickel (II) is bound to Sepharose fast flow resin (Amersham 
Biosciences) by chelation using nitriloacetic acid (NTA) [155].  Two milliliters of 
NTA beads are first washed thoroughly and rinsed with 20 mL of 50 mM EDTA to 
remove interfering trace metals. Next, the resin is rinsed with 20 mL 0.5 mM 
NaCl.  Salt help promote optimal purification.  The salts and EDTA are thoroughly 
diluted by washing the resin with 40 mL deionized water. To charge the resin with 
nickel, the resin is incubated with 40 mL of 0.1 M NiSO4 for a minimum 15 min.  
After the nickel solution is removed the now Ni2+- NTA- beads were rinsed with 
40 mL of deionized water.  25 mL protein is added to the resin containing 15 mL 
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0.5 mM imidazole, 420 µL 5 mg/mL PMSF and 210 µL 1 mg/mL TAME protease 
inhibitors.  The resin slurry and protein are allowed to stir in a 250 mL beaker at 
4oC for 1 h.   Low concentrations of imidazole are used to remove low affinity 
bound proteins. The protein is eluted by washing with 1M Hepes buffer, pH 8.0, 
continually increasing concentrations of 40 mL volumes of imidazole (50 mM, 
100 mM, 150 mM, 250 mM, 300 mM) at room temperature using vacuum 
filtration.  The fusion protein normally elutes at 200 mM imidazole.  The purity 
and molecular mass of each fraction was assessed using SDS PAGE. Generally 
the fusion protein is >90% pure. The protein is dialyzed against 4 L 30 mM 
Hepes, 150 mM NaCl,, adjusted to pH 8.0 overnight at 4°C.  After dialysis the 
protein concentration was quantified, and the protein was aliquoted, frozen and 
stored at 20oC.  
 
Protein quantitation: 
 For the CA(II) fusion proteins, the protein concentration was estimated 
using the absorption of the fluorescent protein (ε587nm = 82620 M-1cm-1 for 
CA(II)_mCherry and  ε548 nm = 82620 M-1cm-1 for CA(II)_mOrange).  The 
extinction coefficient for the fusion protein was determined using Vector NTI.  
This is an integrated software program that aids in the creation and manipulation 
of biological molecules based on sequences analysis.  
The concentration of active CA(II) fusion protein was determined by an 
active site titration. As previously discussed, this method accurately measures 
the number of sulfonamide binding sites, ignoring any contaminating protein and 
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any CA(II) incapable of binding sulfonamide. An aliquot of purified fusion protein 
was diluted to a final concentration of 0.5 – 1 µM in 10 mM MOPS, pH 7.0 buffer 
containing 1-2 µM ZnSO4. The excess zinc is present to insure that all of the CA 
in the sample is in the zinc bound form. The fluorescent sulfonamide (4 µM of 
either dansylamide, DNSA or Dps) is added to the protein solution. The 
concentration of the CA(II) bound fluorescent sulfonamide was monitored either 
by FRET between the intrinsic protein fluorescence and DNSA (excitation 290 
nm, emission 450) or by the fluorescence enhancement of Dps (excitation 365 
nm, emission 540 nm) .  The CA(II)-fluorescent sulfonamide complex is then 
titrated with diamox (acetazolamide, Sigma A6011) which has a higher affinity for 
CA(II) (nanomolar) and binds essentially stoichiometrically.  Under these 
conditions diamox binding to CA(II) is essentially stoichiometric (Figure 3.7).  
Two linear fits were performed – the first line was fitted to the initial fluorescence 
decrease (low damox concentrations) and the second line was fitted to the 
plateau region (high diamox concentrations). The intercept of the two linear fits 





Dps affinity of CA(II)_mCherry and CA(II)_mOrange: 
 The fluorescence spectra of CA(II) fusion proteins in the apo-, zinc-bound 
and Dps-bound forms were measured on the AB2 fluorimeter in 10 mM MOPS, 
pH 7.0.  The response of CA(II)_FP for Dps was measured by adding 2-4 µM 




Figure 3:7:  Measuring the concentration of active fusion protein:  
DNSA fluorescence emission (Ex: 290 nm, Em: 450 nm) as a function of diamox 
concentration at 1 µM holo- () CA(II)_mOrange () CA(II)_mCherry with 4 µM 
DNSA, and 2 µM zinc in 10 mM MOPS, pH 7.0. Two linear fits were performed- 
The intercept of the two linear fits yields the concentration of holo-CA(II)_Fusion 





in fluorescence (excitation 365, emission 535 for Dps and excitation 365, 




Preparation of Apo-enzyme:   
To remove the native metal from the purified fusion proteins, 1.5 mL of 
sample was incubated in 25 mM DPA in 10 mM metal-free (chelaxed) MOPS 
buffer, pH 7.0 overnight, followed by chromatography on a PD-10 column 
(Sephadex G-25M, 5cm X 15 cm, Pharmacia) pre-equilibrated with 10 mM metal 
free MOPS buffer, pH 7.0.  Concentration of the resulting enzyme was done 
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using an Amicon Ultra concentrator (Millipore).  All plasticware and pipette tips 
used for preparation of metal free solutions and apo-protein was purchased as 
“metal free” (Bio-Rad) to minimize metal ion contamination.  All solutions were 
made using deionized, 18 MΩ water and were stored in the low metal, pre-
treated plasticware.  The enzyme concentration was then determined using 
absorbance spectroscopy.  The bound zinc ion concentration was determined by 
ICP-MS.  Zinc studies were performed on enzyme containing <10% bound zinc. 
 
Zinc affinity measurements: 
To measure the apparent zinc affinity, 100 nM apo-enzyme was incubated 
with Zn-NTA buffers (See Table). After equilibration at 25°C for 8-12 h, 2 µM Dps 
was added to the protein- buffer mixture and allowed to incubate for 30 min. The 
ratio of the Dps fluorescence (Ex = 365 nm, Em = 535 nm) to the fluorescent 
protein fluorescence (mOrange, Ex = 547 nm, Em= 562; mCherry, Ex = 587 nm, 
Em =610) of each of each sample containing varying free zinc concentrations 
was measured on an AB2 fluorimeter. A single binding isotherm was fit to the 
data to determine the apparent zinc affinity of CA(II)_mOrange and 









The expression of genes in mammalian cells has become increasingly 
important to study a number of biological questions and as a primary method for 
production of proteins for potential medicinal use. Mammalian cells are frequently 
used as a host for expression of foreign genes, because of their compatibility to 
human disorders.  To measure zinc in mammalian cells, Andrea Stoddard (Fierke 
Lab) adapted the CA-based biosensor for uptake by mammalian cells by 
attaching a TAT (―transactivator of transcriptionǁ‖) peptide to CA(II)_mCherry. 
The TAT peptide is encoded by HIV-1 and contains an 11 amino acid (G-Y-R-K-
K-R-R-H-R-R-G) protein transduction domain (PTD) allowing the cell to carry the 
protein across the membrane and into the cytoplasm [156].  Previous studies 
report that TAT-fused fluorescent-labeled CA(II) was rapidly taken up by cells 
with no apparent ill effects in concentrations sufficient to permit fluorescence 
microscopy [157].   
Much of our understanding of zinc transport and its regulation in 
eukaryotes comes from studies of the yeast Saccharomyces cerevisiae [158]. 
Yeast cells transport Zn with high affinity via a plasma membrane-associated 
transport proteins. Additionally, various compartments within the cells have zinc 
transporters that transport zinc into or out of a particular compartment.  More 
specifically, the yeast Saccharomyces cerevisiae is a powerful model system for 
measuring homeostasis of intracellular zinc ions [159].  The use of an expressed 
CA fusion protein in yeast to detect in vivo free zinc has several advantages. 
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This is due to the biochemical similarity to human cells and ease of growth 
and genetic manipulation. The activity of these transporters is regulated at both 
transcriptional and posttranscriptional levels in response to zinc [128], [160].  
These different mechanisms work together to precisely balance zinc uptake and 
its storage and utilization.  
Although very reproducible, stoichiometric methods depend on accurate 
knowledge of the concentration of CA(II) and maintenance of an excess 
concentration of both CA(II) and sulfonamide. Therefore, stoichiometric methods 
do not work for in vivo measurements where the total zinc concentration is high 
(∼0.2 mM) and well buffered by numerous ligands and consequently difficult to 
deplete.  To address these issues, an excitation ratiometric method was 
developed based on Förster resonance energy transfer (FRET) between the cell-
permeable sulfonamide, dapoxyl sulfonamide, and the fluorescent protein fused 
to CA(II) (Figure 3.8). mCherry or mOrange serves as a FRET acceptor for the 
bound sulfonamide, such that emission from the bound sulfonamide is efficiently 





































Figure 3:8:  Schematic representation of ratiometric zinc sensing using 
CA(II)_mCherry:  
Upon zinc binding to CA(II), Dps binds to the holo enzyme, accompanied by a 
large change in fluorescence of mCherry. In the absence of zinc, mCherry (Ex = 
587 nm, Em = 610 nm) fluorescence is observed when excited at 587 nm. Upon 
zinc binding, Dps (Ex = 365 nm, Em = 610 nm (bound)) acts as the FRET donor 







A series of vectors encoding CA(II)_mCherry and CA(II)_mOrange constructs 
have been successfully made.  These different vectors are expected to be useful 
in bacteria and yeast.  Initial characterization of the CA(II)_FP proteins encoded 
by the bacterial and mammalian plasmids, indicate that they have properties 















mOrange 547 562 71,000 0.69 2.5h 
mCherry 587 610 72,000 0.22 0.25h 
Table 3.3:  Spectral characteristics of selected monomeric fluorescent      
proteins:  
The physical properties mOrange and mCherry are shown, including the 
emission wavelength, excitation wavelength, extinction coefficient at that 
wavelength, the quantum yield of the fluorescence, and the half time for 




The spectral characteristics of the fusion protein are listed in Table 3.3 
[127].  The excitation properties of mOrange and mCherry and the overlap of its 
absorbance with the emission of dapoxyl sulfonamide are chosen so that energy 
transfer between the two fluorophores is quantitative based on the concentration 
of  bound zinc.  To demonstrate the utility of Dps as the donating fluorophore to 
excite the fluorescent protein in our zinc binding studies, we first characterized 
the spectrum profiles of apo- and holo- forms of the fusion protein pre- and post 
















Figure 3:9:  CA(II)_mCherry and CA(II)_mCherry emission spectra in the 
absence and presence of Dps:  
A;C) Emission spectra of purified CA(II)_mCherry in 10 mM MOPS, 4 µM Dps, 
1.0 µM ZnSO4, pH 7.0 in the absence (⎯) and presence (⎯) of Dps. The 
emission from the fluorescent protein increases upon binding of Dps to the holo-
enzyme when excited at 365 nm. B) Emission spectra of CA(II)_mOrange in the 
absence (⎯) and presence (⎯) of Dps. Dps bound to holo-WT-CA(II) is also 
featured in each set (⎯) 
 
 




shown for comparison purposes.  Later, dissociation constants were determined 
by monitoring the increase in fluorescence (excitation = 365 nm, emission 
wavelength of the fluorescent protein) relative to the emission of the fluorescent 
protein only upon binding Dps to CA(II).  
In particular, the spectral characteristics in the presence and absence of 
Dps with CA-mOrange and CA-mCherry are suited for zinc sensing under in vivo 
conditions.  Upon addition of the Dps to CA_mOrange under in vivo conditions, 
an increase in the mOrange fluorescence is observed (Figure 3.9) at 562 nm 
when Dps is excited at 365 nm, demonstrating FRET. The FRET signal for 
mOrange  (547 nm) is difficult to distinguish from the Dps emission (535 nm) 
because the spectral overlap emission is too large (Figure 3.9).   
Similarly, with CA_mCherry, a shoulder is observed at 610 nm, at the 
right-hand side of the mCherry peak at approximately 610 nm when excited at 
365 nm indicating FRET due to the large difference between the emission 
maximum for Dps (535 nm) and the excitation maximum of mCherry (587 nm) 
leading to poor spectral overlap and a smaller FRET signal upon Dps binding. 
The change in signal observed at 535 nm in the presence of Dps suggests that 
the binding of sulfonamides is not compromised.             
Additionally, these ratiometric zinc sensors using CA(II) fused to a 
fluorescent protein with Dps bound were investigated in the presence of a 
increasing amounts of competing inhibitor, exthoxzolamide and diamox (See 














Figure 3:10:  Emission spectra of Dps bound-CA(II)_mCherry in the 
presence of a non-fluorescent competitor inhibitor:  
Dps fluorescence emission (Ex: 365 nm, Em: 535 nm) as a function of increasing 
concentrations of ethoxzolamide when added to 1 µM holo-() CA(II)_mCherry, 
4 µM Dps, and 2 µM zinc in 10 mM MOPS, pH 7.0.  Comparable profiles were 




fluorescence at 535 nm was extinguished.  Both of these aryl sulfonamides can 
displace CA(II)-Zn2+-Dps complexes-time of signal loss being dependent on 
competitor concentrations. This method proves that Dps is bound to the active 
site of CA(II)-non-specific binding of Dps to the protein is not occurring. 
Further characterization of the fusion proteins required us to determine the 
apparent zinc affinity of the CA(II)_mCherry and CA(II)_mOrange sensors.  The 
inherent affinity of zinc to CA(II) will not change, but it is hypothesized that in the 
presence of the bulky fluorescent protein, the apparent affinity will be altered. 
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The measurement of the binding constants in the nanomolar and less regime will 
call for the maintenance of “free” metal ion concentrations well below the 
concentration of total metal concentration of the ion of interests as well below the 
limit of detection when interfering metal ions may be present intracellularly.   The 
well-designed buffer system as discussed in Chapter 2 is useful here as well.  
(See Table 3.4)   In this approach, also considering future in vivo studies, we 
assume that the quantity of the zinc complexed to NTA will be much larger the 
total of zinc sequestered by other molecules (inorganic salts, proteins) will be 
negligible.  Basically, NTA acts as the chelator so that the small losses of metal 
ions from solution that occur upon binding to a protein or surface are 
compensated for by re-equilibration of the chelator bound metal with the bulk 
solution [66].  It should be noted that the free metal ion concentration range of 
our buffer series is compatible with the expected dissociation constant of the 
fusion protein for that zinc. Like WT-CA(II) and its previously discussed mutants, 
the binding studies of the fusion proteins were performed at free zinc ion 
concentrations in the picomolar range.  
Zinc (II) binding to CA(II) is observed as a fluorescence resonance energy 
transfer (FRET) signal between the membrane-soluble fluorophore, dapoxyl 
sulfonamide, that binds specifically to the CA(II)-Zn fusion protein and not to apo-
CA(II) fusion protein.  The Kd values for Zn2+ binding to mCherry and mOrange 
carbonic anhydrase sensors were determined from changes in excitation 
ratiometric fluorescent measurements to be 5.3 ± 0.9 pM, and 1.8 ± 0.3 pM, 





 [Zn], total M 
[Zn], Free 
M 2X [Zn], total M 
Bufffer #    
Control Control Control Control 
1 1.00E-09 2.13E-15 2.00E-09 
2 5.00E-09 1.06E-14 1.00E-08 
3 1.00E-07 2.13E-13 2.00E-07 
4 2.50E-07 5.32E-13 5.00E-07 
5 5.00E-07 1.06E-12 1.00E-06 
6 2.00E-06 4.26E-12 4.00E-06 
7 5.00E-06 1.07E-11 1.00E-05 
8 2.50E-05 5.46E-11 5.00E-05 
9 5.00E-05 1.12E-10 1.00E-04 
10 2.00E-04 5.32E-10 4.00E-04 
11 5.00E-04 2.13E-09 1.00E-03 
12 7.50E-04 6.39E-09 1.50E-03 
13 9.00E-04 1.92E-08 1.80E-03 
14 9.60E-04 5.10E-08 1.92E-03 
 
Table 3.4:  Zinc(II) metal buffer series:  
This is a set of free zinc (II) calibration buffers made with MOPS as the pH buffer 
and NTA as the metal ion buffer.  The final free zinc concentrations in 2 mM 
NTA, 10 mM MOPS buffer, pH 7.0, 25oC is µM-pM.  Note: This is a 2X buffer: 



















Figure 3:11:  Fluorescence of apo-CA(II)_mVariant as a function of the free 
zinc concentration:  
The fluorescence of 100 nM apo-CA(II)_ ()m_Cherry and ()m_Orange in 10 
mM MOPS zinc-NTA buffer with varying concentrations of free zinc, pH 7.0.  The 
ratio of FRET emission  (Ex = 365 nm, Em =  610 nm () or 562nm ()) to the 
fluorescent protein ( Ex = 587 nm, Em =  610 nm () or Ex = 547 nm, Em =  562 
nm ()). A single binding isotherm (Eq 2.3) was fit to the data and a KDApp of 5.3 



























































 In the last decade, several genetically encoded fluorescent sensors have 
been developed based on variants of Green Fluorescent Protein (GFP) and 
fluorescence resonance energy transfer (FRET), a concept that was pioneered 
by Roger Tsien [161]. Early applications of genetically encoded sensors used 
Blue Fluorescent Protein (BFP) as the donor and GFP as the acceptor, but the 
low quantum yield and photostability of BFP soon led to the use of Cyan and 
Yellow Fluorescent Proteins (CFP and YFP, respectively) as donor and acceptor 
proteins in FRET-based sensors. For CFP and YFP an R0 of 48 Å has been 
determined[162]. Since FRET efficiency depends on the distance and orientation 
of the fluorophores, it also can be an effective way to detect conformational 
changes on the scale of individual proteins or small molecules. 
 Intracellular imaging of sensors have been applied in imaging a variety of 
small molecules including calcium [48], cAmp [163], maltose [164], nitric oxide 
[165], and glucose [166]. In these sensors, fluorescent proteins are fused to 
proteins that naturally bind the target, combining the advantages of a genetically-
encoded with a high affinity for target of interest.  
The major intent of this work was to construct and optimize the CA(II) 
based sensor for zinc using an expressible and ratiometric approach.  The 
advantages of a ratiometric approach for quantitative imaging free metal ion 
concentrations allow freedom from variations in excitation intensities, specimen 
thickness and fluorophore concentrations due to photobleaching [157].  
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Considering the FRET efficiencies, zinc affinities and stability of the sensor at 
physiological pH conditions, it was promising from the in vitro characterization 
experiments that the fusion proteins were ideal for in vivo imaging.   In efforts to 
elucidate the biology of zinc and its role in disease, we have designed an 
expressible, ratiometric sensor with CA(II) as the receptor molecule fused to the 
engineered intrinsically fluorescent proteins, mCherry and mOrange.  These 
sensors can be expressed in bacteria, yeast or mammalian tissue culture cells.  
The novelty of this sensor design, establishes a convenient means for 
utilizing the fusion protein to test a variety of biological conditions that may alter 
free zinc in the cells. These in vitro experiments suggest that this CA(II)-
fluorescent protein fusion is a novel candidate as an expressible, in vivo sensor 
for ratiometric fluorescence imaging of intracellular Zn2+. Because the 
chromophore of the fluorescent protein forms in vivo and Dps and the non-
fluorescent sulfonamides are membrane permeable, this ratiometric zinc sensor 
can be expressed and analyzed in situ, dismissing the need to purify and/or label 
the sensor protein.  However, the hydrophobic nature of Dps is something of a 
disadvantage for FRET based zinc sensing in vivo.  Dps might bind to 
phospholipid bilayers such as that in the cell membrane mimicking the emission 
bound to CA(II).  Because Dps partitions into membranes reversibly, we 
hypothesize that it will desorb from the membrane to bind to holo CA(II)_FP 
[167].  In addition, the method presented definitely saves money and time spent 
during protein preparations.  The most recent application, investigations to test 
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 An important prerequisite for further understanding the mechanism of zinc 
homeostasis and its involvement in diseases is the ability to image the 
concentration of these metals in living cells in real time. To study intracellular 
processes, it is necessary to have a detection system that allows sensitive, non-
invasive, real-time imaging of metal ions in single living cells with high spatial 
resolution.  Fluorescence microscopy is well suited for this purpose and the 
development of fluorescent probes that bind transition metal ions with high 
affinity and selectivity is an area of active research [106], [100], [168]. A variety of 
Zn(II)-specific fluorescent dyes have been developed [169], [170], [171] and 
recently the first two versions of Cu(I)-specific fluorescent chemosensors were 
reported [172], [173]. Although several of these sensors have already been used 
for intracellular imaging [174], small molecule sensors with physiologically 
relevant binding constants have been challenging to develop.  Additionally, a 
major disadvantage of chemosensors or biosensors conjugated with synthetic 
dyes is the challenge of inserting them into cells. In efforts to develop biosensor 
for metal ions that could be adapted for in vivo purposes, several groups have 
developed fluorescent sensors based on natural metal binding proteins.   Protein-
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based fluorescent Zn(II) sensors include fluorescently labeled peptides based on 
Zn-finger domains [168], the carbonic anhydrase-based sensors in combination 
with a Zn2+- specific fluorescent substrate inhibitor [175] and green fluorescent 
protein (GFP) variants with Zn(II) binding sites introduced by protein engineering 
[50].  The latter have the important advantage of being genetically-encoded (i.e., 
no synthetic fluorescent groups are used.  However, the GFP and zinc finger 
peptides do not have sufficient affinity to report on intracellular zinc 
concentrations.  
  A key advantage of genetically encoded sensor proteins is that these 
sensors consist entirely of amino acids and can be produced intracellularly.  In 
addition, attachment of signal sequences and regulation of transcription allows 
control over their subcellular localization and over the intracellular sensor 
concentration [176], [177]. Finally, these sensors can be optimized for metal 
selectivity and affinity using mutagenesis and selection methods [178], [179]. As 
described in Chapter 3, we have chosen to prepare fusion proteins with mCherry 
and mOrange, two of the latest red versions of fluorescent proteins derived from 
the Discosoma sp. (DsRed) that have faster maturing chromophores in the 
monomeric form [127]. 
 To analyze intracellular concentrations of metal ions or other ligands, a 
ratiometric fluorescent method is essential since this eliminates many artifacts 
[157].  Our ratiometric approach for imaging metal ions is based on the change in 
the efficiency of fluorescence resonance energy transfer (FRET) between a 
donor molecule and acceptor fluorescent protein [180].  
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  An important benefit of FRET-based sensors is the generation of a 
ratiometric signal. Ratiometric detection provides a measure of the binding state 
that can be made independent of the absolute concentration of the sensor, which 
is important to obtain reliable and quantitative results in biological samples. Tsien 
and coworkers pioneered this concept by constructing the calcium sensor 
Cameleon in which the calcium binding protein calmodulin was fused to two 
spectral variants of GFP [161].  Calcium binding to calmodulin induces a 
conformational change in these fusion proteins that brings the donor and 
acceptor domains closer together which results in increased FRET. Unlike 
synthetic fluorescent probes which need to be introduced inside the cell via 
microinjection or passive diffusion, genetically- encoded sensors consist entirely 
of amino acids and can be produced inside cells by transcription and translation 
of their corresponding genes.  
 In this chapter, to the goal is to demonstrate the measurement of free 
cytosolic Zn2+ levels in E.coli, using fluorescence microscopy, with the 
ratiometric, genetically encoded CA(II)_mCherry sensor described in Chapter 3.  
This signal is not dependent on the sensor concentration.  To determine the 
readily exchangeable or “free” zinc concentration, for the observed signal, the 
intracellular FRET signal was measured in situ as zinc concentration was 







MATERIALS AND METHODS 
 
Expression and purification of CA(II) fusion proteins: 
For in vitro measurements, the CA(II)_FP (CA_mCherry and 
CA_mOrange were expressed and purified as described in detail in Chapter 
3. In short, expression plasmids (p23a_CA_mOrange, p23a_CA_mCherry, 
pAHT_CA_mCherry and p24aH_CA_mCherry) were transformed into E. coli 
BL21(DE3). Protein expression was induced in 0.5 L culture by addition of 1 
mM IPTG at OD600 = 0.6-0.8, after which cells were grown at 25 °C and 220 
rpm for six h and then harvested by centrifugation at 6000g at 4°C for 15 min.  
The cell pellet was disrupted using a microfluidizer in buffers supplemented 
with protease inhibitors. The fusion proteins were purified using nickel affinity 
column chromatography. Apo-enzyme was prepared by incubation with DPA 
as described in Chapter 3.  
 
Growth of cells for imaging: 
 A single colony of BL21(DE3)  in 5 mL of (1X A medium (7.6 mM 
(NH4)2SO4, 33 mM KH2PO4, 60 mM K2HPO4, and 1.7 mM sodium citrate) (ref) 
supplemented with 40 mg/ml of all 20 essential L-amino acids (Sigma), 0.2% 
glucose, 1 mM MgSO4, and 5E-5 % thiamine) and 100 mg/mL ampicillin and 
incubated at 37°C overnight.   All media components except thiamine and 
MgSO4 were incubated overnight with 50 g/liter Chelex 100 resin (Bio- Rad) prior 
to mixing to remove trace metals, mixed and sterile-filtered before use.  The 
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following procedure was used to prepare E. coli expressing Ca(II)_mCherry 
fusion where the fluorescent chromophore in the protein is fully mature.  This 
media provides a low total zinc and reproducible concentrations.  Media recipes 
prepared from tryptone and yeast extract have variable higher total zinc 
concentrations. 
Overnight cultures were diluted 1:50 into fresh minimal medium and 
incubated at 25 °C until the OD600 reached 0.2-0.3. Expression of the 
CA_mCherry fusion protein was induced by addition of 0.2 mM IPTG and 
incubated at 25 °C 12-14 h.  1 mL of induced sensor cells were spun down, 
washed with fresh medium to rid any residual IPTG, resuspended in 5 mL 
medium and incubated for 2-3 h at 30 °C. This strategy allows sufficient time for 
the sensor to mature prior to imaging. Achieving a slower rate of expression has 
been attempted by reducing incubation temperatures to 25 oC and using a series 
of IPTG concentrations between 5-500 mM.  The multiples of samples were 
expressed and prepared for imaging accordingly the protocol described above. 
  
FRET microscopy: 
Fluorescent images were acquired using a Nikon Eclipse TE2000-U 
epifluorescence microscope through a Nikon Plan Fluor 100×/1.3 NA oil 
immersion objective with a Photometrics CoolSNAP HQ cooled CCD camera. 
For FRET measurements, a 400DCLP dichroic mirror (Chroma Technology) 
and two filters (Chroma; D350/50X, HQ575_50x and HQ625_30m) alternated 
by a Lambda filter wheel. All filters and dichroic mirrors were purchased from 
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Chroma Technology Corp. The complete filter sets for fluorescence imaging 
are summarized in Table 4.1. Live cell images and solution measuremnts 
were acquired using a 50-ms exposure time for the FRET channel and using 
a 500-ms exposure time for the acceptor channel. After acquisition, the 
images were manipulated using MetaMorph software package (Molecular 
Devices). Background values were subtracted from the images collected in 
each channel.  These adjusted values also took into consideration 
interference by background fluorescence from the cells.  This also corrected 
for fluorescence from membrane-bound Dps. Final data analysis of the 























CA(II)_mOrange D350/50x 500ms HQ530_30x 50ms 550 dcxru HQ580_40m_2p 
CA(II)_mCherry D350/50X 500ms HQ575_50x 50ms 605 lpxru 
HQ625_30m 
Dapoxyl D350/50x 50ms N/A 500ms 400 dclp HQ535_30m 
 
 







Imaging live E. coli cells: 
 To immobilize bacteria on a glass bottom 96-well plate (MatriCal 
Bioscience), the glass was derivatized with poly-L-lysine in accordance to the 
following method [181]. In preparation of imaging, 2 mL of cells were plated on 
poly-L-lysine-coated glass 96-well plates and equilibrated with the appropriate 
solutions. Each plate was rinsed in 18 MΩ water, soaked in ethanol containing 
5% (w/v) potassium hydroxide for 10 min, rinsed with water and then soaked in a 
solution of 0.05% poly-L-lysine in water (Sigma P8920) for 5 min. After a final 
rinse with water, the slides were allowed to dry at 37°C for 1 – 2 h. 
Before imaging, 2 mL of cell culture (prepared as described above) 
was added to a single well and incubated until dry.  The media was removed 
and incubated with inhibitor for 20 min at room temperature.  Dps and 
ethoxzolamide were prepared fresh on the day of use as 200 mM and 100 
mM stock solutions in DMSO, respectively. Concentrations of 50 mM, 200 
mM, 500 mM ZnSO4 diluted in 100 µL fresh MOPS medium, were added to 
the 96-well plate containing immobilized E. coli cells.  The cells were allowed 
to equilibrate with Zn2+ for 5-10 min and then imaged.  Zinc depletion studies 
were performed by adding 1 mM EDTA dissolved in MOPS medium to the 
cells that were treated with Dps. Images were acquired as above. The signal 
in the FRET and acceptor channels were taken sequentially and measured 
only once at each concentration point. 
The inhibitor solution was then replaced with fresh MOPS media and 
the cells were imaged immediately in both the FRET and FP channels.   A 
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ratio image of FRET/FP was then created, and the average intensity in each 
cell calculated. The free Zn2+ concentration was determined from the in situ 
calibration curve.  
 
In vitro calibration of CA(II) fusion sensors:  
The apparent zinc affinities of the CA(II)_fusion protein sensors were 
measured by microscopy in MOPS NTA-chelated zinc buffers with known free 
zinc concentrations (described in Chapter 3).  Homogeneous solutions of 100 nM 
purified apo- CA(II)_mOrange and CA(II)_mCherry sensors were equilibrated 
with a series of zinc buffers plus 2 mM dapoxyl sulfonamide for 30-270 min at 
room temperature.  Fluorescent images were taken in the two channels, FRET 
and FP, as described in Table using the Nikon Eclipse microscope. The ratio 
FRET/FP was plotted against the free zinc concentrations, and a single binding 
curve was fit to the data. 
 
 
In situ calibration of CA(II)_mCherry: 
Da Wang, a graduate student in the Fierke Lab, developed a method 
to calibrate the dependence of the FRET/FP CA(II) fusion proteins on the 
Zn2+ concentration in situ. The E. coli cells are treated with 100 mL of 1 mM 
EDTA in 10 mM metal free MOPS buffer for 15 min followed by a wash with 
100 µL fresh MOPS buffer.  Then 100 µL MOPS-NTA-Zn buffers (pH 7.6) 
containing 30 µM digitonin (made fresh from 30mM stock in DMSO) and 2 µM 
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Dps (made fresh from 200 µM stock in DMSO) were added to each well 
containing cells and incubated for 20 min at room temperature.  The cells 
were then washed once with a MOPS-NTA-Zn buffer and incubated for 40 
min.  Finally, the cells were images using the CA_mCherry and FRET 
channels as described above.  The FRET/FP ratio was plotted against the 






















Calibration of CA(II)_Fluorescent Protein in microscope: 
 The long-range goal of the development of a CA(II)-based zinc biosensor is 
to prepare an easily usable, fluorescent sensor to measure intracellular zinc 
concentrations.  Drawbacks of using the TAT-tagged, Alexa-Fluor-labeled CA(II) 
biosensor to measure intracellular zinc are that it is complicated to use not 
applicable to all cell lines and types and the apparent zinc affinity is not well 
matched to the intracellular zinc concentration.  A genetically encoded sensor 
overcomes many of these challenges. 
 The preparation of genes and expression plasmids encoding CA(II)_FP as 
well as a zinc-dependent calibration curve of this sensor measured in a 
fluorimeter were described in Chapter 3.  To demonstrate that a similar zinc-
dependent change in the fluorescence (FRET/FP) ratio (emission at 625 nm, 
excitation at either 350 nm (FRET) or 575 nm (FP), we measured a calibration 
curve using purified CA_mCherry or CA_mOrange in a 96-well glass bottom 
plate on the microscope.  ‘’Apo-CA(II)_FP was equilibrated with zinc-NTA buffers 
that varied the zinc concentration and the FRET/FP ratio was measured after 
addition of Dps. The Kd,app for zinc measured from these data are 5.0± 3 pM and 
2.8± 0.8 pM for CA(II)_mCherry and CA(II)_mOrange, respectively.  These 
values are comparable to the values of 5.0± 1 pM and 1.8± 0.4 pM for 
CA(II)_mCherry and CA(II)_mOrange measured in the fluorimeter (Fig 3.11 , 
Chapter 3).  Da Wang performed the same procedure on CA(II)_mCherry purified 
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Figure 4:1:  In vitro caiibration curve of CA_mOrange and CA_mCherry 
encoded in p23a_CA_mCh or p23a_CA_mOr:  
100 nM apo-CA_FP sensor was pre-equilibrated with MOPS NTA-chelated zinc 
buffers (pH = 7.0) and 2 µM Dps at room temperature. FRET/FP excitation 
intensity ratios were taken in 96-well glass bottom plates using the fluorescence 
microscope.  () in vitro calibration curve of CA_mOrange with 3-Gly linker  () in 
vitro calibration curve of CA_mCherry sensor with 3-Gly linker.  A single binding 
isotherm is fit to the data 
 
 
 For the calibration, total zinc levels were in excess of the sensor 
concentration allowing the free zinc concentration to be buffered at fixed low 













































the ratiometric change was large enough to be detected using a fluorescence 
microscope.  The binding curves at pH 7.0 for the sensors are shown in Figure 
4.1 and the in vitro data is summarized in Table 4.2.  The variability of the Kd 
measurements of CA(II)_mCherry can be attributed to the sequences differences 
(addition of the HIS tag) between the parent vectors.  Also, FRET/FP ratio 
measured for the zinc-response curves are in the same range as those 
measured in the fluorescence spectrophotometer.  
 
 
            Calibration Curve        











pH 7.0  
(Figs. 1-2) 
In situ,    
microscope 
 
pH 7.58  
(Fig.) 
CA_mCherry 5± 1 pM 5±3 pM Not determined 
CA_mCherry_pET24A Not determined 23± 3 pMa 68± 34 pM 
TAT_CA_mCherry Not determined Not determined 46± 26 pM 
CA_mOrange 1.8±0.4 pM 2.8±0.8 pM Not determined 
 
Table 4.2:  Binding data for CA(II) fused to fluorescent proteins comparing 
in vivo and in situ responses to free zinc:  
Dissociation constants (Kd, apparent) were calculated using a single binding 







Preparation of cells for zinc measurements: 
Our observation that Zn(II) can mediate an interaction between Dps and 
mCherry by causing the energy transfer in vivo, prompted us to investigate the 
metal ion dependency by first considering growth conditions. Data suggests that 
higher concentrations of zinc and the types of growth medium have significant 
effect on how fast the protein expresses relative to how complete the 
chromophore matures.  As a control, the effect of Zn2+ was determined without 
external metal dependent interactions between the donor and acceptor proteins 
by imaging cells grown in LB, 2XYT and minimal media. Using ICP-MS to 
compare total zinc levels across the media types, minimal media exhibit 5-10-fold 
lower zinc levels than those reported for rich media types.  The results show that 
the intracellular level of free zinc is indeed total zinc-dependent and validate our 
sensing results obtained in the FRET experiments in the previous chapter.  
Cells grown in medium with higher zinc levels normally exhibited higher 
intracellular free zinc concentrations, with less measurable signal changes, 
however without significant growth abnormalities (data not shown).  These 
results suggest that the rate of expression versus chromophore maturation is 
disproportionate.  This also implies, that E. coli cells, in order to conserve energy 
necessary to maintain intracellular free zinc concentrations, can develop greater 
tolerances to higher total zinc concentrations over time.   
It is difficult to predict the presence of intramolecular Zn2+ mediated 
complexes intracellularly when no values of association constants have been 
determined. The acquirement, distribution, delivery and excretion of metals is a 
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tightly regulated process, which results in very low free metal concentrations in 
cells.  The motivation driving this work yields the assumption that there is an 
exchangeable zinc pool in the cell that will not be challenged by the binding of 
zinc to carbonic anhydrase.  Under this assumption, elevated sensor levels 
should not alter this zinc homeostasis.   
Perhaps the easiest method for generating desired amounts of soluble 
protein in E. coli is to create conditions that reduce the rate of expression. 
Theoretically, as we hypothesized, in efforts to optimize growth conditions, 
lowering the expression rate allows the protein to fold properly and remain in 
solution. The Zn2+ affinities of the CA_mCherry protein constructs (5 to 68 pM) 
are well suited to probe free Zn2+ concentration in the low to mid- picomolar 
range in cells.  Previous data suggest that an expressible sensor that is present 
in the nM-µM range can probe these low concentrations without significant 
perturbation of zinc homeostasis because the total cellular zinc is 0.2-0.5 mM 
and the sensor can equilibrate with this total pool [182].  Therefore, the cellular 
milieu acts as an efficient buffering system for metals such as Zn2+ [76]. 
However, to minimize the perturbation of metal homeostasis, the sensor 
concentration should be as low as possible. 
On the other hand, expression of CA_mCherry must be sufficient to 
reliably measure changes in FRET emission upon Dps binding over the 
background fluorescence due to Dps binding to the membrane.  To measure the 
intracellular zinc concentration of E. coli, we surveyed the effect of growth 
environment in order to determine optimal conditions for protein expression in E. 
 
 127 
coli that will produce measurable signals when illuminated using the microscope. 
When expressing this protein in bacteria for purification purposes, chromophore 
maturation lifetimes were less of a concern as the chromophore matures prior to 
harvesting cells and continues to mature during purification. For in vivo studies, 
however, a fully matured chromophore is critical. mCherry is the fastest-maturing 
red monomeric fluorescent protein known to date.  Unfortunately, our signal 
outputs are less than optimal because mCherry when fused to CA(II) is less 
bright, and it’s near far-red excitation spectrum does not pair well with Dps 
emission, resulting in lower FRET efficiencies than we expected.  mOrange on 
the other hand is the brightest monomeric protein derived from dsRed, but it is 
more pH sensitive, when fused to CA takes 2.5 times longer to reach full 
maturation and the extent of FRET overlap creates interfering background 
signals that can not be distinquished in our current zinc sensing approach.  The 
in vivo work presented in this chapter was therefore limited to results generated 
using the CA_mCherry sensor. 
 
FRET Signal Depends on CA(II)_mCherry Binding Dps and Zinc: 
 The imaging experiments that show CA(II)_mCherry is well expressed in E. 
coli.  Furthermore, this signal is dependent on both Dps and zinc binding to 
CA(II)_mCherry.  To evaluate the amount of background energy transfer, the 
spectral bleed-through parameters were determined.  The donor bleed-through 
was determined in cells that do not express CA(II)_mCherry 
(BL21(DE3)_pET23a).  Addition of Dps causes little increase in fluorescence in 
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the FRET channel (Figure 4.2), indicating the membrane-bound Dps does not 
interfere. In contrast, in cells expressing CA(II)_mCherry (BL21(DE3)_pET23a), a 
large increase in signal in the FRET channel is observed upon addition of Dps 
(Figure 4.2).  Also Dps does not bind free zinc in the media or any sulfonamide 
bound to the membrane did not generate interfering signals.  
To further confirm that the observed signal is due to Dps binding 
specifically to CA(II), the FRET/FP ratio in the zinc-bound state of cells 
expressing CA(II)_mCherry (BL21(DE3)_pET23a) that were equilibrated and 
saturated with ethoxzolamide was measured.  The ideal condition was to 
show that the observed ratio is generated from specific binding of Dps to 
holo-enzyme. Recall, ethoxzolamide is a non-fluorescent sulfonamide 
inhibitor that acts as a competing ligand to dapoxyl.  Once bound forms of the 
sulfonamide were determined according the protocols discussed, the free zinc 
concentration can be calculated in the same manner as for the wavelength 
ratiometric approaches baseline.  Upon addition of 30 mM ethoxzolamide to 
cells treated with 2 mM Dps, fluorescence intensities of the FRET/FP ratio 
were quenched to levels as low as those observed for the CA(II)_FP minus 
Dps excited in the FRET channel (Figure 4.2).  This experiment proved the 
specificity of the signal that originates from the zinc-bound CA(II)_mCherry 
sensor.  
Furthermore, we examined whether the FRET/FP ratio is sensitive to 
changes in extracellular zinc. Incubation of BL21(DE3)_pET23a cells expressing 
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CA(II)_mCherry with 1 mM EDTA  prior to addition of Dps was corrected out.  E. 
coli is a gram- 
 
Figure 4:2:  Fluorescence signal of the pET23A vector transformed in 
BL21(DE3) cells treated with inhibitor:  
A-C) E. coli expressing pET24a vector void CA(II)_FP gene incubated with 100 
mL 2 mM Dps. D-F) E. coli expressing pET23a vector with CA(II)_mCherry gene 
incubated with 100 mL 2 µM Dps. A single image was acquired with the FRET 
channel: Ex350/ Em625, exposure time 500ms.   Undetectable levels of 
background fluorescence from the FP channel was observed from membrane 
bound Dps; G-I) CA(II)_mCherry +/- Dps J-L) CA(II)_mCherry after addition of 
100 mL 2 µM Dps and 100 mL 30 mM ethoxzolamide. Images were similarly 










negative bacterium that has an outer membrane to act as an extra barrier 
against the perfusion of divalent ions.  Lipopolysacchride (LPS) is an important 
structural component of the outer member and it is stabilized by divalent ions. 
Short incubation of the cells with the EDTA can disrupt the structure of outer 
membrane by destabilizing LPS, leading to a significant decrease in the 
FRET/FP ratio (Figure 4.3) within a 15-minute time frame [183].  This result 
demonstrates both that the zinc bound to CA(II) is labile and that the chelation of 
extracellular zinc leads to a net efflux of zinc from the cells.  
 In contrast, incubation of the E. coli cells with high extracellular zinc 
leads to an increase in the FRET/FP ratio (Figure 4.3).  This result also 
demonstrates that intracellular zinc is affected by the extracellular concentration 
and that CA(II) equilibrates with the zinc pool.  In response to zinc, these cells 
can modulate zinc via membrane receptors or channels.  Binding of zinc 
resulted in a minimum ten-fold increase in fluorescence. These experiments 
show that the sensor reflects the intracellular zinc concentration. 
 
FRET signal does not depend on sensor concentration: 
To examine whether the FRET/FP ratio, and therefore the apparent zinc 
concentration depends on the sensor concentration, CA(II)_mCherry expression 
was altered by varying the IPTG at induction concentrations up to 1 mM.  This 
alteration in IPTG concentration led to an non-proportional change in sensor 
concentration (Figure 4.4), while the FRET/FP ratio remained stable.  The best 
fluorescent signal is observed at higher sensor concentrations.  However, at very  
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Figure 4:3:  Altering extracellular Zn2+ affects the FRET/FP ratio and 
intracellular free Zn2+ concentration:  
E. coli expressing CA(II)_mCherry (BL21(DE3)) were incubated with 2 µM Dps 
for 10 min, then 1-500 µM of zinc sulfate (or 1 mM EDTA) diluted in fresh MOPS 
media for 5 min.  The FP signals (ex= 575; em= 625) and FRET (ex= 350; em= 
625) signals were imaged in the microscope. plotted against total zinc 
concentrations.  The FRET/FP ratio is calculated.  Extrapolation of the image 





high expression levels, chromophore maturation is limited and protein 
aggregation observed.  Therefore, the CA(II)_mCherry expression at 50-200 mM 
IPTG was optimal for sensing. Future studies will also use this protocol to track 
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stages of growth, image and quantitate free zinc concentrations at desirable 
points along the cell’s life cycle. 
 
Quantification of  “free” zinc in E. coli: 
The intracellular free zinc concentration of E. coli cultured in minimal 
medium at log phase was measured using CA(II)_mCherry.  In summary, 
expression plasmids were transformed into chemically competent E. coli 
BL21(DE3). Minimal medium used for culturing cells was supplemented with 
100 µg/mL ampicillin to select for cells expressing CA(II)_mCherry protein. To 
quantify the concentration of zinc designated by a given FRET/FP ratio image 
in E. coli, an in situ calibration curve was determined.  A main challenge to 
this experiment was the development of a method to equilibrate intracellular 
zinc with extracellular zinc buffers to set the “free” concentration.  Since the 
zinc affinity of CA(II) is dependent on the pH, the calibration curves were 
carried out at pH 7.6, the likely cytosolic pH of E. coli [183].  As shown in 
Figure 4.5, the FRET/FP ratio of E. coli cells expressings CA(II)_mCherry 
varies with the “free” zinc concentration of the Zn-NTA buffers.  This 
calibration curve varies from the in vitro calibration curves both in terms of an 
increase in the Kd, app  and the terms of the actual values of the FRET/FP 
ratios.  This is due to the differences in the intensity of the emission signals 
generated (based on the efficiency of expression and chromophore 
maturation) from the FP.  Therefore, the in situ calibration is essential for 
estimating the intracellular zinc concentration.  Measurement of the FRET/FP 
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ratio of reproducibility for many cells expressing the fusion sensor, grown in 
minimal media gives a value of ~0.3.  The in situ calibration curve indicates 
that histogram number extrapolates to an intracellular “free” or readily 





              
             
 
Figure 4:4:  Expression levels of the CA(II)_mCherry sensor in BL21 (DE3) 
cells do not affect FRET/FP ratio:  
A) Fluorescence imaging of E.coli expressing BL21(DE3) p23a_CA_mC cells 
grown as described in materials and methods with CA(II)_mCherry expression 
varied by addition of increasing concentrations of IPTG. B) The E. coli cells 
induced with varying concentrations of IPTG were lysed by sonication and the 
cell lysate was fractionated on a 12% SDS-PAGE gel.  The CA(II)_mCherry band 
is shown at each IPTG concentration tested. C) The FRET/FP ratio from imaging 
BL21(DE3) p23a_CA_mC cells induced with varying IPTG concentrations was 
measured from imaging the cells  and is not dependent on sensor concentration.  




















Figure 4:5:  In situ calibration curve of the modified versions of 
CA(II)_mCherry:  
2mL E. coli cells expressing CA(II)_mCherry were treated with 100 µL 1 mM 
EDTA in MOPS media.  The cells were equilibrated with 100 µL MOPS NTA-
chelated zinc buffers (pH = 7.6)  with 2 µM Dps and 30 µM digitonin for 40 min at 
room temperature. FRET/FP excitation intensity ratios were taken in 96-well 
glass bottom plates using the fluorescence microscope. () in vitro calibration 
curve of BL21(DE3)_p24aH_mCherry encoding the CA(II)_mCherry_His sensor 
with 3-Gly linker. () in vitro calibration curve of BL21(DE3)_pAHT_CA(II)_mCh 
encoding the TAT_CA(II)_mCherry sensor with 3-Gly linker.  Each data point 
represents a single (2-channel) acquisition taken at the known free zinc 














































































In the current study, CA(II)_mCherry was tested as a protein based sensor 
to probe free zinc concentrations in E. coli via intracellular imaging. We have 
shown that fusing CA(II) to mCherry via a short flexible tri-glycine linker does not 
disrupt important sensor properties. Having established the correct expression of 
CA(II)_mCherry, fluorescence microscopy experiments were performed on E. coli 
BL21(DE3) cells expressing CA(II)_mCherry.  In order to accurately quantitate 
free cytosolic zinc, the differences in cellular environment and fluorescence 
instrumentation optics were voided. Calibrating the FRET/FP ratio in the 
presence of cells allowed us to determine the cells’ response to zinc in real time. 
These in situ or quantitative calibrations were used to discern the numerical 
value for the resting, readily exchangeable zinc concentration in E. coli.  
These data clearly shows an increase in FRET signals between Dps and 
mCherry upon titration of Zn2+, as expected, and this increase reflects the zinc 
concentration. 
More importantly, the fact that zinc is able to form a stable complex with 
CA(II)_mCherry expressed in E. coli with an apparent dissociation constant 
consistent with reported cysolic free zinc concentrations in bacteria raises 
interesting biological questions concerning Zn2+ transport and storage in vivo. 
A fundamental assumption calculating the intracellular zinc concentration for the 
FRET/FP ratio and the calibration curve is that CA(II) is at thermodynamic 
equilibration with intracellular zinc.  For CA(II)_mCherry, the zinc binding kinetics  
imaged in the cell occur within 20-40 min. To examine this assumption, Bozym et 
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al. tested two versions of the TAT-tagged, Alexa Fluor labeled carbonic 
anhydrase-based zinc sensors in PC-12 cells: one with a slow association rate 
constant of 105 M-1 s-1 and the other with a single site mutation (E117A) that 
increases the association rate constant by 800-fold [157]. They found that in 
these cells both sensors reach equilibrium in ~5 min. This rapid equilibration 
suggests that zinc binding processes are catalyzed by chaperones or small 
molecule-zinc complexes such as glutathione.  This translates to CA(II) binding 
as a zinc complex which is at higher concentration than pM, therefore, 
CA(II)_mCherry, which concentration estimates are near mM, likely also binds 
zinc rapidly in cells. 
In conclusion, we have developed a new generation of divalent metal 
sensors that can be utilized to measure low levels of free Zn2+ in various cell 
types. Optimization of the brightness and maturation lifetimes of this sensor will 
provide better visualization at lower expression levels. Furthermore, the current 
sensor system can be optimized by improving the relatively small difference in 
energy transfer that is observed upon binding of the metal.  Lastly, by altering 
metal selectivity via mutagenesis this sensor can be used to probe 
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CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS 
 
 Carbonic anhydrases are archetypical zinc metalloenzymes and as such, 
they have been developed as the recognition element of a family of fluorescent 
indicators (sensors) to detect metal ions, particularly Zn2+ and Cu2+.  WT CA(II) 
having a high affinity for both copper and zinc (Chapter 2) is known for its 
unmatched selectivity.  Inherent limitations of selectivity still can present a 
problem for the application of these proteins in the studies of metal distribution in 
seawater and potentially cellular imaging of either of these metals. The original 
aim of this study was to elucidate the selectivity for either Cu2+ or Zn2+ by site 
directed mutagenesis of residues in the active site of CA(II) [132]. In an effort to 
develop a more copper specific sensor, single mutations were made at positions 
92 and 199 in human CA(II). It was shown that the affinity for zinc in all tested 
mutant proteins was significantly decreased, as Zn(II) needs at least four 
coordinating ligands for binding. Subtle differences in coordination geometry can 
have major effects on metal specificity.  More research is necessary to establish 
whether a more copper specific active site can be further optimized to enhance 
the specificity for copper over zinc when in contaminating metal environments.  
Nevertheless, the question of metal specificity is also important to consider for 
proteins that can be used to better understand metal homeostasis [184].  
 Fluorescent probes for imaging Zn2+ are known to and will continue to have 
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a major technical impact on biomedical research and related diseases for 
decades to come [41], [25].  Consequently, the major focus of this thesis was to 
develop a method to measure intracellular zinc via a ratiometric FRET-based 
sensor protein. Until recently, no examples of other ratiometric sensor proteins 
for zinc with pM sensitiviy that can be applied to live-cell imaging had been 
reported. The expressible sensors described in this thesis were based on the 
carbonic anhydrase platform.  To create a FRET system, a series of red 
fluorescent proteins were fused to CA(II) via a tri-glycine linker.  Energy transfer 
is observed when, in the presence of Zn2+ bound to the active site of CA(II) Dps 
acts as a donor to excite the fluorescent proteins, mOrange and mCherry.  The 
Zn(II) affinity of the single protein sensor was found to depend on the gene’s 
sequence, FRET overlap and chromophore maturation half lives,  ranging from 2 
pM to 60 pM.  Zinc binding resulted in the formation of a stable tertiary complex 
that was insensitive to changes in the intracellular metal concentrations.  
Mutagenesis  studies of the metal binding sites were attempted to probe the 
selectivity for  Zn2+ in the fusion protein, but the preliminary work will be further 
developed. 
 Our cell imaging experiments with CA_mCherry and TAT_CA_mCherry 
have been optimized showing that the sensor is well expressed in bacteria.   In 
addition, energy transfer was clearly observed with great response upon addition 
or depletion of zinc. Further improvements to our system will be to optimize 
protocols for expressing the fusion sensors in yeast and mammalian cell types. 
 The protein concentration of CA(II)_mCherry when expressed in BL21(DE3) 
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cells is not well established, concentrations studies suggest values  in the range 
of 20-50 mM. This protein concentration and the measured free zinc 
concentration in the cytosol of E. coli is not unrealistic, suggesting that 
CA(II)_mCherry-Zn-Dps complexes could be formed in other cell types. A second 
important indication that this complex can be formed in vivo came from our zinc 
repletion and deletion studies which we observed a steady increase in FRET/FP 
ratios upon addition of Zn(II) to the extracellular millieu.  More pronounced is our 
manipulation of FRET/FP ratios by the chelation of Zn with   EDTA.  All signal 
outputs were confirmed via our in vivo exthoxzolamide studies-proving changes 
in emission intensities are zinc dependent. 
  Determination of the intracellular concentration of free Zn inside living cells 
is a major step forward as the exact concentration of these metals in mammalian 
cells is better understood, but still remains an unsolved issue.  Our expressible 
sensor which has a zinc affinity in the pM range can probe these low 
concentrations, because cells act as an efficient buffering system for metals such 
as Zn(II) [76]. The free Zn(II) concentration could therefore be very low, but at the 
same time the total zinc concentration inside cells is much higher ( µM), which is 
more than sufficient to saturate the sensor.  
 The CA(II)_mCherry (and CA(II))_mOrange) sensors described in 
this thesis have many attractive features for application as intracellular imaging 
tools for Zn. However, higher levels of expression of sensor might be necessary 
for reliable visualization in mammalian and yeast cells, which may interfere with 
normal functions of the cells. In our current yeast vector series, protein 
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expression is under the control of the galactose inducible, glucose repressed 
GAL1 promoter. Because these vectors do not result in adequate protein 
expression for fluorescence imaging, the constitutive PMA1 promoter is an even 
stronger yeast promoter [185]. PMA1 was not selected for the initial work 
because constitutive expression of a metalloproteins such as CA(II) were thought 
to may have a potential detrimental effect on the cells. 
  Furthermore, the current sensor system can be tweaked by improving the 
relatively small difference in energy transfer that is observed upon binding of the 
metal and by probing the metal selectivity for other biological relevant metals. 
Alternative sensor designs employing different fluorescent proteins variants are 
being studied [186]. These variants were selected because of excitation and 
emission spectra, enhanced brightness, and improved pH resistance.  The 
enhanced brightness of these proteins is determined by several factors, including 
the faster maturation speed and efficiency, higher extinction coefficients, 
improved quantum yields and photostability.  Replacement of the fluorescent 
proteins with these new variants in our expressible sensor design also allows 
more effective quantitative FRET imaging due to the close spectral overlap of the 
donor emission and acceptor absorption, resulting in a larger Förster distance.  
CA(II)_mCherry and CA(II)_mOrange are reported to have dissociations 
constants that are ideal, but exhibit a relatively small change in FRET/FP ratio of 
~ 30% upon zinc binding.  Varying linker length may prove to be as reasonable 
aapproach to increase the ratiometric change without sacrificing the lower 
apparent affinity for zinc. 
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The ability to image the concentration of transition metals in living cells in 
real time at a high resolution is considered a huge success for our lab.  The 
research described in this thesis yielded new insights into the mechanism of 
metal homeostasis and metal specificity. Furthermore, this work provides 
important lessons for the rational design of a FRET-based sensors in general. 
The current sensor design can be employed to address more specific zinc 
dependent responses that result from more extreme growth and environmental 
conditions (i.e oxidative and nitrosative stress) and ultimately metals and their 
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